SEARCH
検索詳細岩田 育子 (イワタ イクコ)
| 北海道大学病院 | 講師 |
日本神経学会認定神経内科専門医
日本内科学会総合内科専門医
日本認知症学会専門医
ICD(日本神経感染症学会)
研究者基本情報
■ 学位■ URL
researchmap URLホームページURL■ ID 各種
研究者番号
- 30776779
研究キーワード研究分野■ 担当教育組織
経歴
■ 経歴経歴
- 2026年11月 - 現在
北海道大学病院, 軽度認知障害センター, 講師 - 2024年12月 - 現在
北海道大学病院, 軽度認知障害センター, 講師, 日本国 - 2021年04月 - 2024年11月
北海道大学病院, 脳神経内科, 助教, 日本国 - 2016年04月 - 2021年03月
北海道大学大学院医学研究院, 神経病態学分野神経内科学教室, 助教 - 2012年04月 - 2016年03月
北海道大学大学院, 神経病態学講座神経内科学分野, 博士課程 - 2012年04月 - 2013年04月
帯広厚生病院, 神経内科, 医長 - 2010年10月 - 2012年03月
帯広厚生病院, 神経内科, 医員 - 2009年10月 - 2010年09月
北海道大学病院, 神経内科, 医員 - 2009年04月 - 2009年09月
北祐会神経内科病院, 神経内科, 医員 - 2008年04月 - 2009年03月
旭川赤十字病院, 神経内科, 医員 - 2007年04月 - 2008年03月
北海道大学病院, 神経内科, 医員 - 2006年04月 - 2007年03月
旭川赤十字病院, 臨床研修センター, 初期臨床研修医 - 2005年04月 - 2006年03月
北海道大学病院, 臨床研修センター, 初期臨床研修医
研究活動情報
■ 論文- A Novel Presenilin-1 Variant (p.Phe283Val) in Early-Onset Mild Cognitive Impairment With Striatal Amyloid Accumulation
Ikuko Takahashi-Iwata; Akihiko Kudo; Taichi Nomura; Shintaro Fujii; Katsuki Eguchi; Hisashi Uwatoko; Shinichi Shirai; Masaaki Matsushima; Hiroaki Yaguchi; Takashi Ozaki; Yuichi Nakamura; Takahiro A. Kato; Norikazu Hara; Takeshi Ikeuchi; Ichiro Yabe
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2026年09月16日
英語 - Continuing decline of multisystemic subtypes and increasing unidentified cases in autosomal dominant spinocerebellar ataxia under health insurance coverage in Hokkaido.
Keiichi Mizushima; Shinichi Shirai; Yuka Shibata; Masaaki Matsushima; Ikuko Takahashi-Iwata; Hiroaki Yaguchi; Ichiro Yabe
Journal of the neurological sciences, 490, 126146, 126146, 2026年08月14日, [国際誌]
英語 - Detection of TDP-43 Proteinopathies in Brain and Cerebrospinal Fluid Using Seed Amplification Assay.
Katsuya Satoh; Mika Inada Shimamura; Takeshi Fujimoto; Michio Kitayama; Akio Akagi; Yasushi Iwasaki; Yuu Satoh; Katsuhiro Ichinose; Akira Satoh; Ikuko Takahashi Iwata; Ichiro Yabe
Current issues in molecular biology, 48, 8, 2026年08月13日, [国際誌]
英語, 研究論文(学術雑誌), Misfolded TAR DNA-binding protein 43 (TDP-43) is the primary pathological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). While seed amplification assays (SAAs), such as real-time quaking-induced conversion (RT-QuIC), have shown promise in detecting misfolded TDP-43 in cerebrospinal fluid (CSF) and olfactory mucosa, technically accessible methodologies are urgently required for widespread clinical application. We developed a streamlined, non-immunoprecipitation-based TDP-43 RT-QuIC assay to assess seeding activity in brain tissue and CSF. We evaluated its diagnostic performance using CSF from patients with TDP-43 proteinopathies and control subjects, and further examined its association with neurofilament light chain (NfL) and tau-related biomarkers. In CSF analysis, the assay demonstrated positive seeding activity in 70% (21/30) of patients with ALS and dementia, 50% (5/10) of patients with FTLD, and 40% (8/20) of patients with ALS alone. The assay exhibited excellent specificity, yielding negative results in >99% (199/200) of control samples, including those with autoimmune or electrophysiological abnormalities. Furthermore, CSF analysis demonstrated significantly higher NfL levels in TDP-43 SAA-positive cases compared to SAA-negative cases (p < 0.0008). The highest NfL concentrations were observed in the SAA-positive ALS with dementia and ALS cohorts, contrasting with lower levels in FTLD. Tau-related biomarkers exhibited no significant differences between the groups. Our streamlined, non-immunoprecipitation TDP-43 RT-QuIC assay provides highly specific detection of pathological TDP-43 seeding activity. While the assay detects the underlying TDP-43 proteinopathy rather than distinguishing between ALS and FTLD clinical phenotypes, its technical simplicity and combined utility with NfL measurements offer a robust, scalable framework for biomarker development. This approach provides a practical foundation for future multi-center validation and international standardization efforts. - An investigation of factors associated with speech intelligibility in patients with amyotrophic lateral sclerosis: Integrating acoustic and lingual motor measures.
Yohei Tsujisawa; Ikuko Takahashi-Iwata; Ichiro Yabe; Masahiko Mukaino; Isamu Shibamoto
Clinical linguistics & phonetics, 1, 20, 2026年07月22日, [国際誌]
英語, 研究論文(学術雑誌), Speech intelligibility in amyotrophic lateral sclerosis (ALS) progressively declines, but contributing clinical factors may vary according to disease presentation and extent of bulbar involvement. This study examined factors associated with intelligibility in three ALS groups: spinal-onset, spinal-onset with bulbar involvement (spinal + bulbar), and bulbar-onset. Speech intelligibility (visual analogue scale), hypernasality, maximum tongue pressure, respiratory function (%VC and FEV1/FVC), and second formant (F2) transition measures (transition duration and excursion) were evaluated. Exploratory two- and three-dimensional visualisations were used to examine interrelationships among variables, and regression analyses were conducted in groups with sufficient sample size. In spinal-onset ALS, only hypernasality was associated with intelligibility. In bulbar-onset ALS, both tongue pressure and hypernasality were significantly associated with intelligibility, while preserved F2 excursion showed an additional trend towards better intelligibility. In the spinal + bulbar group, descriptive findings suggested that reduced tongue pressure and increased hypernasality were associated with lower intelligibility. These findings suggest that speech intelligibility in ALS is influenced by different combinations of bulbar-related impairments depending on clinical presentation and extent of bulbar involvement. In particular, tongue strength, velopharyngeal function, and residual tongue mobility may be relevant to intelligibility outcomes with bulbar involvement. Combined evaluation of these measures may help inform individualised clinical assessment and management. - A Novel p. (Leu173del) Mutation in the Presenilin 1 (PSEN1) Gene in Two Sisters with Dominantly Inherited Alzheimer's Disease.
Shintaro Fujii; Ikuko Takahashi-Iwata; Masaaki Matsushima; Hiroaki Yaguchi; Atsushi Takatsuka; Norikazu Hara; Takeshi Ikeuchi; Ichiro Yabe
Internal medicine (Tokyo, Japan), 2026年07月18日, [国内誌]
英語, 研究論文(学術雑誌), We report two sisters with dominantly inherited Alzheimer's disease carrying a novel presenilin 1 (PSEN1) mutation. Case 1 presented with depression at 39 years of age, gradually developed dementia and involuntary movements, and died at 51 years of age. Case 2 presented with dementia at 46 years of age, which progressed gradually, with no other neurological symptoms. The mother also had early onset dementia. A novel c.517_519del, p. (Leu173del) mutation in exon 6 of PSEN1 (NM_000021.3), confirmed by Sanger sequencing, was identified in both cases. Patients with PSEN1 mutations present with diverse neurological symptoms. Therefore, a careful follow-up is recommended. - Nationwide screening identifies an expanded clinical spectrum of anti-KLHL11 antibody-associated neurologic disease in Japan.
Jing Pan; Hiroaki Yaguchi; Akihiko Kudo; Shintaro Fujii; Hanko Sato; Kazuki Yamada; Hisashi Uwatoko; Jiahe Yang; Taichi Nomura; Katsuki Eguchi; Shinichi Shirai; Ikuko Takahashi-Iwata; Masaaki Matsushima; Takuya Okamoto; Haruna Akanuma; Saori Adachi; Taro Ishiguro; Hiroya Kuwahara; Keiko Tanaka; Akio Kimura; Shin Hisahara; Kazuaki Kanai; Sonoko Misawa; Takayoshi Shimohata; Yuji Takahashi; Hidehiro Mizusawa; Ichiro Yabe
Journal of neurology, 273, 6, 2026年05月19日, [国際誌]
英語, 研究論文(学術雑誌), OBJECTIVE: To define the clinical spectrum and treatment responses of anti-Kelch-like protein 11 (KLHL11) IgG-associated neurological syndromes by screening a large, expanded cohort of patients with suspected autoimmune cerebellar ataxia (ACA), autoimmune encephalitis (AE), and related neurological disorders. METHODS: In this retrospective, observational study, serum samples from 930 patients collected from over 100 medical institutions across Japan between 2002 and 2025 were screened. The study population was categorized into five cohorts: cerebellar ataxia (CA) of unknown etiology (n = 778), AE (n = 49), brainstem encephalitis (n = 2), myelitis (n = 12), and multiple system atrophy (MSA) (n = 89). Anti-KLHL11 antibodies were detected using a fixed cell-based assay with HEK293T cells. Cerebrospinal fluid was analyzed in all serum-positive cases. RESULTS: Anti-KLHL11 antibodies were identified in four cases, three males and one female with a mean onset age > 60 years, all showing dual positivity in serum and cerebrospinal fluid. The clinical phenotypes consisted of predominantly CA (n = 2), combined limbic encephalitis (LE) and CA (n = 1), and isolated LE associated with small-cell lung cancer (n = 1). Notably, none of the cases were associated with testicular tumor. While typical paraneoplastic presentations were observed, one patient had no detectable malignancy and improved with immunotherapy alone, and another showed neurological recovery following treatment of a non-testicular tumor. Anti-KLHL11 antibodies were absent in all disease controls with MSA. CONCLUSIONS: Expanding our initial findings, this nationwide study indicates that anti-KLHL11 antibody-associated ACA and AE are rare but increasingly recognized in Japan and may be under-recognized globally. The clinical spectrum of anti-KLHL11 antibody-associated neurological diseases is broad, including females and individuals without a detectable testicular tumor. Importantly, patients presenting with AE may show more favorable responses to immunotherapy or tumor-directed treatment than those with isolated CA, highlighting the importance of early recognition and phenotype-specific management. - [Tuberculosis of the Central Nervous System].
Ikuko Takahashi-Iwata
Brain and nerve = Shinkei kenkyu no shinpo, 78, 5, 469, 474, 2026年05月, [国内誌]
日本語, 研究論文(学術雑誌), Tuberculous meningitis is a condition in which Mycobacterium tuberculosis affects the central nervous system. Although it does not present particularly distinctive symptoms, it often diverges from the classic signs seen in other forms of meningitis. Careful history-taking is essential for suspecting the diagnosis. Genetic testing has become increasingly important in diagnostic methods. Regarding treatment, not all recommendations from international guidelines can be applied domestically. Moving forward, there is a need to establish guidelines for tuberculous meningitis that leverage Japan's strengths. - Utility of Simple Speech Measures in Amyotrophic Lateral Sclerosis Assessment: Focus on Alternating Motion Rate as a Screening Tool.
Yohei Tsujisawa; Ikuko Takahashi-Iwata; Ichiro Yabe; Masahiko Mukaino; Isamu Shibamoto
Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP), 1, 16, 2026年01月09日, [国際誌]
英語, 研究論文(学術雑誌), INTRODUCTION: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by progressive degeneration of motor neurons. Early detection of bulbar symptoms is crucial for timely diagnosis and intervention; however, variability in symptom progression complicates clinical assessment. METHODS: This retrospective observational study aimed to classify patients with ALS into three groups - spinal onset, spinal onset with bulbar involvement, and bulbar onset - and to identify speech evaluation metrics that effectively differentiate these groups. Data from 68 patients with ALS were retrospectively analyzed. Speech samples were collected and evaluated for alternating motion rate (AMR), maximum phonation time (MPT), nasality, maximum tongue pressure (MTP), speech rate, and speech intelligibility. Group comparisons and receiver operating characteristic (ROC) curve analyses were conducted to assess discriminatory ability. RESULTS: AMR significantly differed among the three groups, with the spinal-onset group demonstrating the highest rates and the bulbar-onset group showing the lowest rates. ROC analysis indicated that AMR exhibited excellent discriminatory power, particularly in distinguishing spinal-from bulbar-onset ALS. Significant differences were also observed in MTP, nasality, speech rate, and speech intelligibility, although some metrics were less effective in differentiating the intermediate group. No significant group differences were found in MPT. CONCLUSION: These findings suggest that the AMR is a sensitive and easily administered measure for detecting bulbar symptoms and distinguishing ALS subtypes. The intermediate characteristics observed in the spinal-onset with bulbar involvement group support this classification as a distinct clinical phenotype. Combining AMR with secondary measures such as MTP, nasality, speech rate, and speech intelligibility may enhance early detection of bulbar symptoms and improve clinical decision-making. - A genome-wide association study identifies the GPM6A locus associated with age at onset in ALS.
Ryoichi Nakamura; Genki Tohnai; Naoki Atsuta; Yumi Matsuda; Satoru Morimoto; Daisuke Ito; Masahisa Katsuno; Yuishin Izumi; Mitsuya Morita; Ikuko Iwata; Ichiro Yabe; Tomoko Nakazato; Nobutaka Hattori; Takehisa Hirayama; Osamu Kano; Asako Tamura; Naoki Suzuki; Masashi Aoki; Kazumoto Shibuya; Satoshi Kuwabara; Masaya Oda; Rina Hashimoto; Ikuko Aiba; Tomohiko Ishihara; Osamu Onodera; Toru Yamashita; Hiroyuki Ishiura; Kota Bokuda; Toshio Shimizu; Yoshio Ikeda; Kazuko Hasegawa; Fumiaki Tanaka; Takanori Yokota; Kazuaki Kanai; Yu-Ichi Noto; Ryuji Kaji; Hirohisa Watanabe; Tomoko Konishi; Mikiko Hasegawa; Hozuki Fukaya; Jun-Ichi Niwa; Manabu Doyu; Yohei Okada; Shiho Nakamura; Fumiko Ozawa; Hideyuki Okano; Masahiro Nakatochi; Gen Sobue
Communications biology, 8, 1, 1720, 1720, 2025年12月05日, [国際誌]
英語, 研究論文(学術雑誌), Amyotrophic lateral sclerosis (ALS) exhibits considerable clinical variability, such as differences in age at onset (AAO). Multiple factors, including genetic factors, may underlie this variability; however, the specific determinants remain unclear. To identify genes affecting AAO, we have conducted a genome-wide association study in Japanese patients with ALS (discovery cohort: n = 1808; replication cohort: n = 207). Here, we show that the minor A allele of rs113161727 at the ADAM29-GPM6A locus is associated with a younger AAO in the discovery cohort (effect, -4.27 years; p = 4.60 × 10-8); this finding has been confirmed in the replication cohort (p = 0.0068) and meta-analysis (p = 1.08 × 10-9). Among 65 ALS patients with a SOD1 mutation, the AAO has been found to be 10.2 years younger in those with the A allele than in those without it (p = 0.002). This variant correlates with GPM6A upregulation in iPSC-derived motor neurons, suggesting GPM6A as a candidate AAO modifier. Overall, our study highlights the impact of genetic modifiers on ALS heterogeneity and provides a potential target for delaying disease onset. - Leukoencephalopathy with primary familial brain calcification: A rare phenotype associated with a novel SLC20A2 frameshift.
Akihiko Kudo; Hiroaki Yaguchi; Taichi Nomura; Hisashi Uwatoko; Shinichi Shirai; Ikuko Takahashi-Iwata; Masaaki Matsushima; Takahiro Yamada; Ichiro Yabe
Clinical neurology and neurosurgery, 259, 109207, 109207, 2025年12月, [国際誌]
英語 - 脳生検により診断に至った難治性神経好中球病の1例
岩波 太志; 山田 一貴; 田中 大貴; 佐藤 凡功; 川北 カイキ; 真島 慧太; 中村 俊太郎; 大岩 慧; 野村 太一; 工藤 彰彦; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 大前 敬祐; 氏原 匡樹; 山口 秀; 種井 善一; 田中 伸哉; 矢部 一郎
臨床神経学, 65, 11, 846, 846, (一社)日本神経学会, 2025年11月
日本語 - 軽度認知障害患者における握力が認知機能へ及ぼす影響
岩田 育子; 松島 理明; 中村 悠一; 尾崎 孝爾; 熊谷 聡美; 加藤 隆弘; 矢部 一郎
Dementia Japan, 39, 4, 654, 654, (一社)日本認知症学会, 2025年10月
日本語 - 神経疾患に対するDoctor to Patients with Doctor形式のオンライン診療についての検討
上床 尚; 宮崎 雄生; 野村 太一; 工藤 彰彦; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 津坂 和文; 保前 英希; 浦 茂久; 松岡 健; 濱田 晋輔; 宮岸 隆司; 深澤 俊行; 堀内 一宏; 新野 正明; 菊地 誠志; 矢部 一郎
日本難病看護学会誌, 30, 2, 202, 202, (一社)日本難病看護学会, 2025年10月
日本語 - Trends in Invasive Interventions and Risk Factors for Early Critical Events in Multiple System Atrophy.
Monami Tarisawa; Masaaki Matsushima; Akihiko Kudo; Taichi Nomura; Hisashi Uwatoko; Shinichi Shirai; Ikuko Takahashi-Iwata; Ken Sakushima; Hiroaki Yaguchi; Isao Yokota; Naoki Nishimoto; Jun Sawada; Takeshi Matsuoka; Haruo Uesugi; Naoya Minami; Kazuya Sako; Asako Takei; Shin Hisahara; Yasuhiro Kanatani; Akiko Tamakoshi; Norihiro Sato; Ichiro Yabe
Cerebellum (London, England), 24, 5, 152, 152, 2025年09月06日, [国際誌]
英語, 研究論文(学術雑誌), Multiple system atrophy (MSA) is a progressive, adult-onset neurodegenerative disorder involving autonomic failure, cerebellar ataxia, and parkinsonism. Patients often require invasive interventions, such as gastrostomy or tracheostomy, and sudden death is common. This study aimed to elucidate patterns of invasive treatment and identify risk factors for tracheostomy or sudden death within 5 years of onset. In total, 214 patients diagnosed with MSA between November 2014 and October 2024 across 66 institutions in Hokkaido were enrolled in the Hokkaido Rare Disease Consortium for MSA (HoRC-MSA). Patients were grouped by clinical course and interventions. We analyzed use of invasive procedures, including enteral nutrition via gastrostomy, enterostomy, esophagostomy, nasogastric tube insertion, central venous nutrition, tracheostomy, and ventilator support. Multivariable analyses were performed to compare patients with and without early critical events, defined as tracheostomy or sudden death within 5 years of disease onset. Invasive procedures were performed in 63.1% of patients. Patients receiving enteral nutrition and tracheostomy had prolonged survival. Early events correlated with older onset age (mean, 65.9 years), orthostatic hypotension, stridor, and an elevated apnea-hypopnea index (median, 32.45). Patients with preserved activities of daily living (ADL) in the Unified MSA Rating Scale part Ⅳ also had an increased risk of early critical events. Autonomic dysfunction, sleep-disordered breathing, and vocal cord impairment predict key risk factors for early mortality in patients with MSA. Monitoring is necessary, regardless of preserved ADL. The impact of invasive interventions on quality of life should be further explored. - 筋萎縮性側索硬化症患者の発症年齢に関連する新規遺伝的因子の同定
中村 亮一; 藤内 玄規; 熱田 直樹; 松田 侑美; 森本 悟; 伊藤 大輔; 勝野 雅央; 和泉 唯信; 森田 光哉; 岩田 育子; 矢部 一郎; 服部 信孝; 平山 剛久; 狩野 修; 鈴木 直輝; 青木 正志; 道勇 学; 岡野 栄之; 中杤 昌弘; 祖父江 元
臨床神経学, 65, Suppl., S235, S235, (一社)日本神経学会, 2025年09月
日本語 - An Autopsy Case of Amyotrophic Lateral Sclerosis With Sudden Death Showed Histological Features of Lewy Body Disease.
Shunsuke Miyachi; Yuki Oshima; Kazuo Yazaki; Nozomi Futaki; Yusuke Shirai; Zen-Ichi Tanei; Yohei Ikebe; Ikuko Iwata; Hideki Ujiie; Masahiro Onozawa; Satoshi Hirano; Shinya Tanaka; Ichiro Yabe
Neuropathology : official journal of the Japanese Society of Neuropathology, 45, 4, e70009, 2025年08月, [国際誌]
英語, 研究論文(学術雑誌), We present the case of an 81-year-old man diagnosed with probable amyotrophic lateral sclerosis (ALS) based on the Updated Awaji criteria. The patient exhibited progressive motor neuron degeneration with muscle weakness, atrophy, and fasciculations primarily in the right lower limb and later extending to the right upper limb. Three months after being referred to a home care clinic, he collapsed in front of his family members and died. An autopsy revealed phosphorylated TDP-43 pathology consistent with ALS, with involvement of the hypoglossal nucleus, facial nerve nucleus, and medulla oblongata. Interestingly, widespread a-synuclein pathology indicative of diffuse neocortical type Lewy body disease (LBD; Braak stage 6) was identified, despite the absence of clinical parkinsonism or dementia with Lewy bodies (DLB) during his lifetime. The presence of autonomic symptoms such as constipation and urinary retention shortly before death may be attributable to a-synuclein pathology affecting the autonomic nervous system. The coexistence of ALS and LBD underscores the clinical challenge of diagnosing overlapping pathologies, as motor symptoms may obscure signs of LBD. Dopamine transporter imaging or MIBG myocardial scintigraphy might aid in identifying preclinical LBD in ALS patients with atypical symptoms. The patient died of respiratory failure due to extensive organizing pneumonia, but the possibility of sudden cardiac arrest could not be excluded. This case highlights the potential for coexisting neurodegenerative pathologies in ALS, emphasizing the importance of comprehensive evaluation when autonomic symptoms or other atypical features are present. - 2024年度北海道地区におけるプリオン病のサーベイランス状況
岩田 育子; 野村 太一; 大橋 和貴; 小笠原 克彦; 矢部 一郎
臨床神経学, 65, 6, 473, 473, (一社)日本神経学会, 2025年06月
日本語 - GluK2抗体陽性自己免疫性小脳失調症の1例
武石 侑杜; 矢口 裕章; 工藤 彰彦; 藤井 信太朗; 岩田 育子; 穴田 麻眞子; 岩見 昂亮; 芳野 正修; 野村 太一; 木村 暁夫; 田中 惠子; 矢部 一郎
臨床神経学, 65, 6, 473, 473, (一社)日本神経学会, 2025年06月
日本語 - KLHL11抗体が陽性であった自己免疫性小脳失調症の1例
藤井 信太朗; 矢口 裕章; 工藤 彰彦; 野村 太一; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 津坂 和文; 矢部 一郎
臨床神経学, 65, 6, 474, 474, (一社)日本神経学会, 2025年06月
日本語 - 硬膜動静脈瘻を伴う脳静脈洞血栓症による頭蓋内圧亢進により両側視力低下をきたした1例
穴田 麻眞子; 野村 太一; 武石 侑杜; 岩見 昂亮; 芳野 正修; 工藤 彰彦; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 長内 俊也; 藤村 幹; 矢部 一郎
臨床神経学, 65, 6, 474, 474, (一社)日本神経学会, 2025年06月
日本語 - 2024年度北海道地区におけるプリオン病のサーベイランス状況
岩田 育子; 野村 太一; 大橋 和貴; 小笠原 克彦; 矢部 一郎
臨床神経学, 65, 6, 473, 473, (一社)日本神経学会, 2025年06月
日本語 - Lyme neuroborreliosis in Japan: Borrelia burgdorferi sensu lato as a cause of meningitis of previously undetermined etiology in hospitalized patients outside of the island of Hokkaido, 2010-2021.
Masayuki Ohira; Ai Takano; Kentaro Yoshi; Akira Arai; Yashuhiro Aso; Rikiya Furutani; Tadanori Hamano; Ikuko Takahashi-Iwata; Chikako Kaneko; Tohru Matsuura; Norihisa Maeda; Hideto Nakajima; Katsuro Shindo; Toshihiko Suenaga; Kazuma Sugie; Yasuhiro Suzuki; Toru Yamashita; Frederick J Angulo; Juanita Edwards; Cody Matthew Bender; Lisa R Harper; Yoshikazu Nakayama; Shuhei Ito; Andreas Pilz; James H Stark; Jennifer C Moïsi; Hidehiro Mizusawa; Masaki Takao
European journal of neurology, 32, 1, e70005, 2025年01月, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND AND PURPOSE: Clinical manifestations of Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato (Bbsl), include erythema migrans, Lyme neuroborreliosis (LNB), carditis, and arthritis. LB is a notifiable disease in Japan with <30 surveillance-reported LB cases annually, predominately from Hokkaido Prefecture. However, LB, including LNB, may be under-diagnosed in Japan since diagnostic tests are not readily available. We sought to determine if LNB could be a cause of previously undiagnosed encephalitis or meningitis in Japan. METHODS: Investigators at 15 hospitals in 10 prefectures throughout Japan retrieved serum and/or cerebrospinal fluid (CSF) samples collected in 2010-2021 from 517 patients hospitalized with encephalitis or meningitis which had an etiology that had not been determined. Samples were tested for Bbsl-specific antibodies using ELISA and Western blot tests. In alignment with the European Union LNB case definition, a confirmed LNB case had CSF pleocytosis and intrathecal production of Bbsl-specific antibodies and a probable LNB case had a CSF sample with pleocytosis and Bbsl-specific antibodies. RESULTS: LNB was identified in three hospitalized patients with meningitis of previously undetermined etiology: a male resident of Aomori Prefecture was a confirmed LNB case, and two female residents of Oita Prefecture were probable LNB cases. None of the patients with confirmed or probable LNB had traveled in the month prior to symptom onset and none had samples previously tested for LB. CONCLUSION: The identification of previously undiagnosed LNB cases indicates a need for enhanced disease awareness in Japan, particularly beyond Hokkaido Island, and more readily available LB diagnostic testing. - Brain biopsy and metagenomic sequencing enhance aetiological diagnosis of encephalitis.
Yusuke Sakiyama; Jun-Hui Yuan; Akiko Yoshimura; Mika Takeuchi; Yoshimitsu Maki; Takuma Mori; Jun Takei; Masahiro Ando; Yu Hiramatsu; Satoshi Nozuma; Yujiro Higuchi; Hajime Yonezawa; Mari Kirishima; Masayuki Suzuki; Takahiro Kano; Monami Tarisawa; Shunta Hashiguchi; Misako Kunii; Shoki Sato; Ikuko Takahashi-Iwata; Akihiro Hashiguchi; Eiji Matsuura; Shuji Izumo; Akihide Tanimoto; Hiroshi Takashima
Brain communications, 7, 3, fcaf165, 2025年, [国際誌]
英語, 研究論文(学術雑誌), Identifying the aetiology of CNS diseases, regardless of their infectious or non-infectious nature, is often intricate. Next-generation sequencing (NGS) has emerged as a powerful tool for sensitive and unbiased screening of tissue or body fluid specimens. This study aimed to investigate the underlying aetiology of patients with suspected infectious CNS diseases. Between April 2013 and October 2021, we collected brain tissue samples from 33 patients diagnosed with encephalitis or encephalitis-like CNS diseases, obtained via biopsy or autopsy, and underwent metagenomic NGS (mNGS) in conjunction with pathological evaluations. Moreover, we employed PCR-based assays and pathogen-specific immunostaining to corroborate the presence of pathogens within the tissue samples. Among the 33 patients, mNGS elucidated pathogen-specific genomic sequences in 7 cases (21.2%), including halobacteria (archaea), Balamuthia mandrillaris, Epstein-Barr virus, Toxoplasma gondii and herpes simplex virus. Additionally, brain tissue mNGS ruled out known pathogens, identifying 14 cases (42.4%) of non-infectious CNS diseases, which included neoplastic, autoimmune/inflammatory and amyloid angiopathy conditions. The adjustment of therapeutic strategies based on these findings led to improvements in clinical symptoms, imaging outcomes and patient prognosis. Brain biopsy serves as both a direct pathological research target and a valuable source of samples for unbiased high-throughput sequencing. Our study illustrates the reliability of mNGS on brain tissue, which significantly improves the diagnostic rate for suspected encephalitis or encephalitis-like diseases of unknown aetiology. These findings underscore the importance of mNGS in guiding more precise and effective therapeutic interventions for patients in clinical practice. - The importance of early immunotherapy in anti-GluK2 antibody-positive autoimmune cerebellar ataxia: A case report.
Yuto Takeishi; Hiroaki Yaguchi; Akihiko Kudo; Shintaro Fujii; Ikuko Iwata; Taichi Nomura; Mamiko Anada; Kosuke Iwami; Masanao Yoshino; Daiki Tanaka; Keiichi Mizushima; Hisashi Uwatoko; Shinichi Shirai; Masaaki Matsushima; Akio Kimura; Keiko Tanaka; Ichiro Yabe
Journal of the neurological sciences, 467, 123306, 123306, 2024年12月15日, [国際誌]
英語 - Anti-Tr/DNER Antibody-associated Paraneoplastic Neurological Syndrome Presenting Limbic Encephalitis with Anaplastic Large Cell Lymphoma: A Case Report.
Shintaro Fujii; Hiroaki Yaguchi; Ikuko Takahashi-Iwata; Takashi Inoue; Monami Tarisawa; Taichi Nomura; Akihiko Kudo; Hisashi Uwatoko; Shinichi Shirai; Masaaki Matsushima; Riku Miyaishi; Noriyuki Otsuka; Keiko Tanaka; Koji Taniguchi; Masato Takahashi; Shinya Tanaka; Ichiro Yabe
Internal medicine (Tokyo, Japan), 64, 13, 2057, 2061, 2024年12月12日, [国内誌]
英語, 研究論文(学術雑誌), An 82-year-old man presented with acute progressive disturbance of consciousness. We suspected autoimmune limbic encephalitis because of abnormal magnetic resonance imaging findings in the bilateral temporal lobes and cerebrospinal fluid pleocytosis. The patient tested positive for anti-Tr/Delta/Notch-like epidermal growth factor-related receptor (DNER) antibodies, and a tissue biopsy revealed complications of anaplastic large cell lymphoma. Typically, anti-Tr/DNER antibody-associated paraneoplastic neurological syndrome presents with cerebellar ataxia and is complicated by Hodgkin lymphoma (HL). However, there are rare cases that present only with LE and are complicated by tumors other than HL; therefore, aggressive antibody measurement and search for tumors are important. - Amyloid-beta pathology in a case with dementia with Lewy bodies with a rapidly progressive clinical course similar to Creutzfeldt-Jacob disease.
Shintaro Fujii; Ikuko Takahashi-Iwata; Yuki Oshima; Kazuhiro Horiuchi; Zenichi Tanei; Katsuya Satoh; Tetsuyuki Kitamoto; Shinya Tanaka; Ichiro Yabe
Neuropathology : official journal of the Japanese Society of Neuropathology, 45, 3, 241, 247, 2024年12月01日, [国際誌]
英語, 研究論文(学術雑誌), Most cases of dementia with Lewy bodies (DLB) follow a chronic course. However, some cases of rapidly progressive dementia (RPD) are difficult to distinguish from other diseases. Herein, we report how to differentiate DLB presenting with RPD from other diseases and its pathological features, with examples from our own experience. A 70-year-old man with RPD and psychiatric symptoms, including hallucinations and delusions, was transferred to our hospital. We suspected Creutzfeldt-Jakob disease (CJD), but disease-specific tests were all negative. The patient was treated with corticosteroids on the suspicion of an autoimmune condition; however, his symptoms did not improve. Based on the results of nuclear medicine and other tests, we suspected DLB and administered anti-Parkinsonian drugs; however, they were ineffective, and the patient died. Brain autopsy revealed extensive deposits of Lewy bodies, which were pathologically diagnosed as DLB. Additionally, extensive deposition of senile plaques was observed; however, neurofibrillary tangles (NFTs) were not prominent. DLB generally presents as a chronic disease. However, some patients with DLB present with RPD; therefore, the differential diagnosis of other diseases, such as CJD, is very important. In addition, although this case was not diagnosed with Alzheimer's disease (AD) due to the lack of NFTs, extensive amyloid deposition was observed in the brain tissue. Previous reports have described cases of RPD with amyloid deposition alone, and in this case too, it is suggested that amyloid deposition might have had a strong influence on the clinical course of RPD. - 右利きで右半球の障害による発語失行を呈した大脳皮質基底核症候群の1例
岩見 昂亮; 上床 尚; 藤井 信太朗; 赤池 瞬; 穴田 麻眞子; 武石 侑杜; 芳野 正修; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 大槻 美佳; 矢部 一郎
臨床神経学, 64, 11, 845, 845, (一社)日本神経学会, 2024年11月
日本語 - 脳炎・肥厚性硬膜炎【WS】免疫沈降法とショットガンプロテオミクスによる自己抗体測定方法の開発
工藤 彰彦; 矢口 裕章; 渡部 昌; 藤井 信太朗; 野村 太一; 上床 恵; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 田中 惠子; 高橋 秀尚; 畠山 鎮次; 矢部 一郎
神経免疫学, 29, 1, 218, 218, (一社)日本神経免疫学会, 2024年10月
日本語 - Pretreatment pathology study in anti-LGI1 encephalitis.
Kazuki Yamada; Hiroaki Yaguchi; Kaede Ishikawa; Daiki Tanaka; Yuki Oshima; Keiichi Mizushima; Shintaro Fujii; Taichi Nomura; Akihiko Kudo; Hisashi Uwatoko; Shinichi Shirai; Ikuko Takahashi-Iwata; Masaaki Matsushima; Riku Miyaishi; Noriyuki Otsuka; Zen-Ichi Tanei; Shigeru Yamaguchi; Keiko Tanaka; Koji Taniguchi; Shinya Tanaka; Ichiro Yabe
Journal of the neurological sciences, 466, 123258, 123258, 2024年09月27日, [国際誌]
英語 CAG Repeat Expansion inTHAP11 Is Not Detected in a Cohort with Spinocerebellar Ataxia from Hokkaido, the Northernmost Island of Japan
Shinichi Shirai; Keiichi Mizushima; Yuka Shibata; Masaaki Matsushima; Ikuko Iwata; Hiroaki Yaguchi; Ichiro Yabe
Movement Disorders, 39, 9, 1657, 1658, Wiley, 2024年09月17日
研究論文(学術雑誌)- Requirement of Repeated Serum VEGF Measurements in POEMS Syndrome.
Taichi Nomura; Ikuko Iwata; Katsuki Eguchi; Shintaro Fujii; Takashi Inoue; Monami Tarisawa; Takashi Ishio; Yuichiro Toyama; Hisashi Uwatoko; Shinichi Shirai; Masaaki Matsushima; Hiroaki Yaguchi; Ichiro Yabe
Internal medicine (Tokyo, Japan), 2024年08月01日, [国内誌]
英語, 研究論文(学術雑誌), POEMS syndrome is often associated with a poor prognosis. Elevated serum vascular endothelial growth factor (sVEGF) is a useful diagnostic marker with high sensitivity and specificity. However, the relationship between sVEGF elevation and polyneuropathy in POEMS syndrome remains controversial. We herein report a case of polyneuropathy without sVEGF elevation at the first admission. However, at 21 months after the onset, the patient tested positive for sVEGF and was diagnosed with POEMS syndrome. Therefore, it is important to repeatedly measure sVEGF levels in patients with polyneuropathy with an atypical course when POEMS syndrome is suspected, even if the initial sVEGF level is normal. - 血清VEGF値の陽転化で診断に至ったPOEMS症候群の1例
野村 太一; 岩田 育子; 江口 克紀; 井上 貴司; 足澤 萌奈美; 藤井 信太朗; 田中 大貴; 上床 尚; 白井 慎一; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 64, 6, 430, 430, (一社)日本神経学会, 2024年06月
日本語 - 北海道地区のプリオン病サーベイランスと非定型的gCJD
岩田 育子; 阿部 恵; 濱田 晋輔; 白井 慎一; 松島 理明; 矢口 裕章; 江口 克紀; 森若 文雄; 矢部 一郎
臨床神経学, 64, 6, 434, 434, (一社)日本神経学会, 2024年06月
日本語 - 血清VEGF値の陽転化で診断に至ったPOEMS症候群の1例
野村 太一; 岩田 育子; 江口 克紀; 井上 貴司; 足澤 萌奈美; 藤井 信太朗; 田中 大貴; 上床 尚; 白井 慎一; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 64, 6, 430, 430, (一社)日本神経学会, 2024年06月
日本語 - 乾燥症状を伴わずに多彩な神経症状で発症したSjoegren症候群の1例
井上 貴司; 布村 菫; 足澤 萌奈美; 藤井 信太朗; 野村 太一; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 津坂 和文; 小池 春樹; 矢部 一郎
臨床神経学, 64, 6, 431, 431, (一社)日本神経学会, 2024年06月
日本語 - 筋力低下を伴わない高CKの血症を呈したカルパイノパチーの1例
藤井 信太朗; 野村 太一; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 斎藤 良彦; 西野 一三; 矢部 一郎
臨床神経学, 64, 6, 433, 433, (一社)日本神経学会, 2024年06月
日本語 - 北海道地区のプリオン病サーベイランスと非定型的gCJD
岩田 育子; 阿部 恵; 濱田 晋輔; 白井 慎一; 松島 理明; 矢口 裕章; 江口 克紀; 森若 文雄; 矢部 一郎
臨床神経学, 64, 6, 434, 434, (一社)日本神経学会, 2024年06月
日本語 - 今月の症例 腎移植30年後に発症した中枢神経原発移植後リンパ増殖性疾患の1例
石川 楓; 白井 慎一; 上床 尚; 岩田 育子; 松島 理明; 松川 敏大; 山口 秀; 矢口 裕章; 外丸 詩野; 矢部 一郎
日本内科学会雑誌, 113, 6, 980, 985, (一社)日本内科学会, 2024年06月
日本語 - Clinical Characteristics of Patients with Cryptococcal Meningitis in Hokkaido: A Case Series
Monami Tarisawa; Takahiro Kano; Tomoki Ishimaru; Taichi Nomura; Keiichi Mizushima; Kazuhiro Horiuchi; Ikuko Iwata; Shigehisa Ura; Naoya Minami; Hideki Hozen; Ichiro Yabe
Internal Medicine, 63, 9, 1281, 1287, Japanese Society of Internal Medicine, 2024年05月01日
研究論文(学術雑誌) - Lambert-Eaton Myasthenic Syndrome Complicated by Anti-GABAB Receptor Encephalitis.
Kazuki Yamada; Hiroaki Yaguchi; Kaede Ishikawa; Daiki Tanaka; Yuki Oshima; Keiichi Mizushima; Hisashi Uwatoko; Shinichi Shirai; Ikuko Takahashi-Iwata; Masaaki Matsushima; Keiko Tanaka; Ichiro Yabe
Internal medicine (Tokyo, Japan), 63, 9, 1295, 1300, 2024年05月01日, [国内誌]
英語, 研究論文(学術雑誌), A 74-year-old man experienced diplopia, generalized muscle weakness, and acute respiratory failure. He was diagnosed with Lambert-Eaton myasthenic syndrome (LEMS) and treated with immunotherapy, but no improvement was observed, and additional symptoms, including central apnea and hallucinations, appeared. Subsequent serum and cerebrospinal fluid (CSF) analyses confirmed the presence of GABAB receptor antibodies, indicating the coexistence of autoimmune encephalitis. Although there were no findings of malignancy, it is highly likely that occult small-cell lung carcinoma was present. When atypical symptoms occur in patients with LEMS, it is important to consider the possibility of concomitant autoimmune encephalitis. - Spinocerebellar ataxia type 4 is not detected in a cohort from Hokkaido, the northernmost island of Japan.
Shinichi Shirai; Keiichi Mizushima; Yuka Shibata; Masaaki Matsushima; Ikuko Iwata; Hiroaki Yaguchi; Ichiro Yabe
Journal of the neurological sciences, 122974, 122974, 2024年03月20日, [国際誌]
英語 - 非流暢/失文法型原発性進行性失語(naPPA)の臨床症候と画像所見
大槻 美佳; 中川 賀嗣; 緒方 昭彦; 田島 康敬; 濱田 晋輔; 浦 茂久; 金藤 公人; 保前 英希; 赤池 瞬; 岩田 育子; 松島 理明; 矢部 一郎
高次脳機能研究, 44, 1, 72, 73, (一社)日本高次脳機能学会, 2024年03月
日本語 - Reliability of the unified multiple system atrophy rating scale using the telephone
Masaaki Matsushima; Azusa Nagai; Rie Nomachi; Akihiko Kudo; Katsuki Eguchi; Masahiro Wakita; Shinichi Shirai; Ikuko Iwata; Kazuhiro Horiuchi; Takeshi Matsuoka; Shigehisa Ura; Hideki Houzen; Ichiro Yabe
Clinical Neurology and Neurosurgery, 2024年02月
研究論文(学術雑誌) - Pembrolizumab-induced Immune-related Bilateral Vocal Cord Paralysis.
Taichi Nomura; Ikuko Iwata; Shogo Kimura; Ichiro Yabe
Internal medicine (Tokyo, Japan), 63, 22, 3115, 3116, 2024年, [国内誌]
英語, 研究論文(学術雑誌) - Are There Shortages and Regional Disparities in Lecanemab Treatment Facilities? A Cross-Sectional Study.
Kazuki Ohashi; Ikuko Takahashi-Iwata; Zhao Jieyu; Ken Sakushima; Ichiro Yabe; Katsuhiko Ogasawara
Health services insights, 17, 11786329241299312, 11786329241299312, 2024年, [国際誌]
英語, 研究論文(学術雑誌), INTRODUCTION: Alzheimer disease (AD) is the most common type of dementia, affecting 70% of patients with dementia. In Japan, over 5 million people aged 65 years and older had dementia in 2018, and this figure is expected to rise to 25% to 30% of this age group by 2045. In Japan, lecanemab, which was approved in 2023, is expected to be a new treatment for AD. However, lecanemab requires stringent management, including amyloid PET scans and MRI monitoring, necessitating specialized facilities, creating concerns regarding the lack of treatment facilities and poor treatment access. METHODS: This study assessed spatial accessibility to lecanemab in Hokkaido, Japan, using geographic information system data. Hospitals were categorized into 3 scenarios based on their capacity to meet the treatment criteria. Service area analysis in each scenario evaluated the population coverage within 30-, 60-, and 120-minute travel times. The inverted two-step floating catchment area method was used to calculate the potential high-demand areas index (PHDI) for each hospital. RESULTS: Population coverage ranged from 56% to 97%, depending on the scenario and travel time. Coverage for the most feasible scenario (Scenario 1) was 56%, 73.9%, and 88.3% within 30, 60, and 120 minutes, respectively. Northern and southern Hokkaido had the lowest coverage. PHDI analysis identified high-demand areas, with Sapporo facing potential overcapacity issues. CONCLUSION: Lecanemab highlights the need for strategic resource allocation to enhance accessibility and capacity. Establishing additional treatment centers, particularly in areas with poor accessibility and capacity, is crucial to maximize the benefits of treatment for dementia. - 自己免疫性脳炎の診断基準を満たすミエリンオリゴデンドロサイト糖蛋白抗体関連疾患の3例の臨床的特徴
大嶌 祐貴; 上床 尚; 矢口 裕章; 岩田 育子; 金子 仁彦; 高橋 利幸; 田中 惠子; 浦 茂久; 藤原 一男; 矢部 一郎
神経治療学, 41, 1, 64, 68, (一社)日本神経治療学会, 2024年01月
日本語 - First evidence of tick-borne encephalitis (TBE) outside of Hokkaido Island in Japan.
Masayuki Ohira; Kentaro Yoshii; Yasuhiro Aso; Hideto Nakajima; Toru Yamashita; Ikuko Takahashi-Iwata; Norihisa Maeda; Katsuro Shindo; Toshihiko Suenaga; Tohru Matsuura; Kazuma Sugie; Tadanori Hamano; Akira Arai; Rikiya Furutani; Yasuhiro Suzuki; Chikako Kaneko; Yasuhiro Kobayashi; Eduardo Campos-Alberto; Lisa R Harper; Juanita Edwards; Cody Bender; Andreas Pilz; Shuhei Ito; Frederick J Angulo; Wilhelm Erber; Harish Madhava; Jennifer Moïsi; Luis Jodar; Hidehiro Mizusawa; Masaki Takao
Emerging microbes & infections, 12, 2, 2278898, 2278898, 2023年12月, [国際誌]
英語, 研究論文(学術雑誌), Tick-borne encephalitis (TBE) is an infection of the central nervous system caused by the tick-borne encephalitis virus (TBEV). TBE is endemic in parts of Europe and Asia. TBEV is transmitted to humans primarily by Ixodes ticks. There have been 5 TBE cases identified in Japan, all on the northern island of Hokkaido. Rodents with TBEV antibodies and Ixodes ticks have been identified throughout Japan, indicating that TBEV infection might be undiagnosed in Japan. Residual serum and cerebrospinal fluid (CSF) collected in 2010-2021 from 520 patients ≥1 year-of-age previously hospitalized with encephalitis or meningitis of unknown etiology at 15 hospitals (including 13 hospitals outside of Hokkaido) were screened by ELISA for TBEV IgG and IgM antibodies; TBEV infection was confirmed by the gold standard neutralization test. Residual serum was available from 331 (63.6%) patients and CSF from 430 (82.6%) patients; both serum and CSF were available from 189 (36.3%). Two patients were TBE cases: a female aged 61 years hospitalized for 104 days in Oita (2000 km south of Hokkaido) and a male aged 24 years hospitalized for 11 days in Tokyo (1200 km south of Hokkaido). Retrospective testing also identified a previous TBEV infection in a female aged 45 years hospitalized for 12 days in Okayama (1700 km south of Hokkaido). TBEV infection should be considered as a potential cause of encephalitis or meningitis in Japan. TBE cases are likely undiagnosed in Japan, including outside of Hokkaido, due to limited clinical awareness and lack of availability of TBE diagnostic tests. - Case series: Downbeat nystagmus in SCA27B.
Shinichi Shirai; Keiichi Mizushima; Keishi Fujiwara; Eriko Koshimizu; Masaaki Matsushima; Satoko Miyatake; Ikuko Iwata; Hiroaki Yaguchi; Naomichi Matsumoto; Ichiro Yabe
Journal of the neurological sciences, 454, 120849, 120849, 2023年11月15日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Spinocerebellar ataxia (SCA) 27B, first reported in late 2022, is caused by the abnormal expansion of GAA repeats in the first intron of the FGF14 gene, which encodes the fibroblast growth factor 14. CASE PRESENTATION: We present two late-onset cases, each manifesting mild cerebellar ataxia accompanied by omnidirectional downbeat nystagmus, which was enhanced in a suspended head position. None of the patients exhibited impaired head impulse or caloric tests. Repeat-primed PCR and targeted long-read nanopore sequence analysis of the FGF14 GAA repeat site identified more than 250 repeats, leading to the diagnosis of SCA27B. DISCUSSION: Downbeat nystagmus is reported to be associated with disturbances in the suppression of the vestibulo-ocular reflex (VOR). Our patients with SCA27B demonstrated downbeat nystagmus, likely due to a disruption of the VOR at the level of the cerebellar cortex, a potentially characteristic clinical feature of SCA27B. We have included video footages of eye movements recorded using Frenzel goggles for these cases. CONCLUSIONS: Omnidirectional downbeat nystagmus may be a distinctive clinical feature of SCA27B. - 視神経乳頭炎で発症し,髄膜脳炎症状が軽微であった自己免疫性GFAPアストロサイトパチー(GFAP-A)の1例
藤井 信太朗; 井上 貴司; 足澤 萌奈美; 野村 太一; 田中 大貴; 水島 慶一; 工藤 彰彦; 阿部 恵; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 荻野 陽; 矢部 一郎
臨床神経学, 63, 11, 778, 778, (一社)日本神経学会, 2023年11月
日本語 - V180I変異とM232R変異の複合ヘテロ接合性変異を認めた遺伝性プリオン病の一例
井上 貴司; 阿部 恵; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 堀内 一宏; 矢部 一郎
臨床神経学, 63, 11, 780, 780, (一社)日本神経学会, 2023年11月
日本語 - 活動性が高く,妊娠出産に際して再発予防薬選択に苦慮した多発性硬化症の1例
野村 太一; 上床 尚; 山田 一貴; 井上 貴司; 足澤 萌奈美; 藤井 信太朗; 田中 大貴; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 63, 11, 782, 782, (一社)日本神経学会, 2023年11月
日本語 - Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan
Keiichi Mizushima; Yuka Shibata; Shinichi Shirai; Masaaki Matsushima; Satoko Miyatake; Ikuko Iwata; Hiroaki Yaguchi; Naomichi Matsumoto; Ichiro Yabe
Journal of Human Genetics, 2023年10月17日, [国際誌]
英語, 研究論文(学術雑誌), In Japan, approximately 30% of spinocerebellar degeneration (SCD) is hereditary, and more than 90% of hereditary SCD is autosomal dominant SCD (AD-SCD). We have previously reported the types of AD-SCD in Hokkaido, twice. In this study, we investigated the status of AD-SCD mainly due to repeat expansions, covering the period since the last report. We performed genetic analysis for 312 patients with a clinical diagnosis of SCD, except for multiple system atrophy at medical institutions in Hokkaido between January 2007 and December 2020. The median age at the time of analysis was 58 (1-86) years. Pathogenic variants causing AD-SCD due to repeat expansion were found in 61.5% (192 cases). Spinocerebellar ataxia (SCA) 6 was the most common type in 25.3% (79 cases), followed by Machado-Joseph disease (MJD)/SCA3 in 13.8% (43), SCA1 in 6.4% (20), SCA2 in 5.1% (16), SCA31 in 4.8% (15), dentatorubral-pallidoluysian atrophy in 4.8% (15), SCA7 in 0.6% (2), and SCA8 in 0.6% (2). SCA17, 27B, 36, and 37 were not found. Compared to previous reports, this study found a higher prevalence of SCA6 and a lower prevalence of MJD/SCA3. An increasing number of cases identified by genetic testing, including cases with no apparent family history, accurately revealed the distribution of disease types in Hokkaido. - Gait video-based prediction of unified Parkinson's disease rating scale score: a retrospective study.
Katsuki Eguchi; Ichigaku Takigawa; Shinichi Shirai; Ikuko Takahashi-Iwata; Masaaki Matsushima; Takahiro Kano; Hiroaki Yaguchi; Ichiro Yabe
BMC neurology, 23, 1, 358, 358, 2023年10月05日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: The diagnosis of Parkinson's disease (PD) and evaluation of its symptoms require in-person clinical examination. Remote evaluation of PD symptoms is desirable, especially during a pandemic such as the coronavirus disease 2019 pandemic. One potential method to remotely evaluate PD motor impairments is video-based analysis. In this study, we aimed to assess the feasibility of predicting the Unified Parkinson's Disease Rating Scale (UPDRS) score from gait videos using a convolutional neural network (CNN) model. METHODS: We retrospectively obtained 737 consecutive gait videos of 74 patients with PD and their corresponding neurologist-rated UPDRS scores. We utilized a CNN model for predicting the total UPDRS part III score and four subscores of axial symptoms (items 27, 28, 29, and 30), bradykinesia (items 23, 24, 25, 26, and 31), rigidity (item 22) and tremor (items 20 and 21). We trained the model on 80% of the gait videos and used 10% of the videos as a validation dataset. We evaluated the predictive performance of the trained model by comparing the model-predicted score with the neurologist-rated score for the remaining 10% of videos (test dataset). We calculated the coefficient of determination (R2) between those scores to evaluate the model's goodness of fit. RESULTS: In the test dataset, the R2 values between the model-predicted and neurologist-rated values for the total UPDRS part III score and subscores of axial symptoms, bradykinesia, rigidity, and tremor were 0.59, 0.77, 0.56, 0.46, and 0.0, respectively. The performance was relatively low for videos from patients with severe symptoms. CONCLUSIONS: Despite the low predictive performance of the model for the total UPDRS part III score, it demonstrated relatively high performance in predicting subscores of axial symptoms. The model approximately predicted the total UPDRS part III scores of patients with moderate symptoms, but the performance was low for patients with severe symptoms owing to limited data. A larger dataset is needed to improve the model's performance in clinical settings. - 中枢神経感染症の診断と治療に対する髄液多項目核酸検査の効果
岩田 育子; 上床 尚; 白井 慎一; 松島 理明; 矢口 裕章; 石黒 信久; 豊嶋 崇徳; 矢部 一郎
NEUROINFECTION, 28, 2, 117, 117, 日本神経感染症学会, 2023年10月
日本語 - フィンゴリモドの投与間隔と再発予防効果の検討
上床 尚; 佐藤 翔紀; 山田 萌美; 佐藤 和則; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 川島 淳; 深澤 俊行; 矢部 一郎
臨床神経学, 63, Suppl., S320, S320, (一社)日本神経学会, 2023年09月
日本語 - 自己免疫性小脳失調症に対する免疫沈降法と質量分析法を用いた網羅的自己抗体測定方法の開発
工藤 彰彦; 矢口 裕章; 渡部 昌; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 高橋 秀尚; 畠山 鎮次; 矢部 一郎
神経免疫学, 28, 1, 217, 217, (一社)日本神経免疫学会, 2023年09月
日本語 - 視神経脊髄炎関連疾患(NMOSD)に対するサトラリズマブの使用経験
上床 尚; 佐藤 翔紀; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
神経免疫学, 28, 1, 224, 224, (一社)日本神経免疫学会, 2023年09月
日本語 - 視神経脊髄炎関連疾患(NMOSD)に対するサトラリズマブの使用経験
上床 尚; 佐藤 翔紀; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
神経免疫学, 28, 1, 224, 224, (一社)日本神経免疫学会, 2023年09月
日本語 - 自己免疫性小脳失調症に対する免疫沈降法と質量分析法を用いた網羅的自己抗体測定方法の開発
工藤 彰彦; 矢口 裕章; 渡部 昌; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 高橋 秀尚; 畠山 鎮次; 矢部 一郎
神経免疫学, 28, 1, 217, 217, (一社)日本神経免疫学会, 2023年09月
日本語 - 今月の症例 S状結腸にα-synuclein病理を確認した認知症を伴うパーキンソン病の1例
穴田 麻眞子; 工藤 彰彦; 阿部 恵; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 吉田 雅; 種井 善一; 矢部 一郎
日本内科学会雑誌, 112, 8, 1402, 1408, (一社)日本内科学会, 2023年08月
日本語, 74歳男。50歳頃に起立性低血圧や便秘などの自律神経症状が出現した。63歳時に静止的振戦と筋強剛が出現し、パーキンソン病と診断した。その後、認知機能障害と幻視が出現した。経過中にS状結腸捻転を繰り返し、今回、腹腔鏡下S状結腸切除術を施行され、切除標本の病理組織検査で神経叢にα-synucleinの沈着を認められた。本例の経験とこれまでの知見から、消化管神経叢におけるα-synucleinの沈着は、非運動症状を伴うパーキンソン病の進展と関連があることが示唆された。 - 今月の症例 S状結腸にα-synuclein病理を確認した認知症を伴うパーキンソン病の1例
穴田 麻眞子; 工藤 彰彦; 阿部 恵; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 吉田 雅; 種井 善一; 矢部 一郎
日本内科学会雑誌, 112, 8, 1402, 1408, (一社)日本内科学会, 2023年08月
日本語 - 肥厚性硬膜炎加療中に両下肢麻痺と進行性意識障害を呈した髄膜脳脊髄炎の1例
山田 一貴; 水島 慶一; 布村 菫; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
NEUROINFECTION, 28, 1, 35, 35, 日本神経感染症学会, 2023年07月
日本語 - 肥厚性硬膜炎加療中に両下肢麻痺と進行性意識障害を呈した髄膜脳脊髄炎の1例
山田 一貴; 水島 慶一; 布村 菫; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
NEUROINFECTION, 28, 1, 35, 35, 日本神経感染症学会, 2023年07月
日本語 - Sez6l2 autoimmunity in a large cohort study.
Megumi Abe; Hiroaki Yaguchi; Akihiko Kudo; Azusa Nagai; Shinichi Shirai; Ikuko Takahashi-Iwata; Masaaki Matsushima; Naoko Nakamura; Kenji Isahaya; Yoshihisa Yamano; Shinji Ashida; Takashi Kasai; Keiko Tanaka; Masashi Watanabe; Takeshi Kondo; Hidehisa Takahashi; Shigetsugu Hatakeyama; Akira Takekoshi; Akio Kimura; Takayoshi Shimohata; Ichiro Yabe
Journal of neurology, neurosurgery, and psychiatry, 94, 8, 667, 668, 2023年06月01日, [国際誌]
英語 - Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients.
Ryoichi Nakamura; Genki Tohnai; Masahiro Nakatochi; Naoki Atsuta; Hirohisa Watanabe; Daisuke Ito; Masahisa Katsuno; Akihiro Hirakawa; Yuishin Izumi; Mitsuya Morita; Takehisa Hirayama; Osamu Kano; Kazuaki Kanai; Nobutaka Hattori; Akira Taniguchi; Naoki Suzuki; Masashi Aoki; Ikuko Iwata; Ichiro Yabe; Kazumoto Shibuya; Satoshi Kuwabara; Masaya Oda; Rina Hashimoto; Ikuko Aiba; Tomohiko Ishihara; Osamu Onodera; Toru Yamashita; Koji Abe; Kouichi Mizoguchi; Toshio Shimizu; Yoshio Ikeda; Takanori Yokota; Kazuko Hasegawa; Fumiaki Tanaka; Kenji Nakashima; Ryuji Kaji; Jun-Ichi Niwa; Manabu Doyu; Chikashi Terao; Shiro Ikegawa; Koki Fujimori; Shiho Nakamura; Fumiko Ozawa; Satoru Morimoto; Kazunari Onodera; Takuji Ito; Yohei Okada; Hideyuki Okano; Gen Sobue
Journal of neurology, neurosurgery, and psychiatry, 94, 10, 816, 824, 2023年05月04日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Several genetic factors are associated with the pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) and its phenotypes, such as disease progression. Here, in this study, we aimed to identify the genes that affect the survival of patients with sporadic ALS. METHODS: We enrolled 1076 Japanese patients with sporadic ALS with imputed genotype data of 7 908 526 variants. We used Cox proportional hazards regression analysis with an additive model adjusted for sex, age at onset and the first two principal components calculated from genotyped data to conduct a genome-wide association study. We further analysed messenger RNA (mRNA) and phenotype expression in motor neurons derived from induced pluripotent stem cells (iPSC-MNs) of patients with ALS. RESULTS: Three novel loci were significantly associated with the survival of patients with sporadic ALS-FGF1 at 5q31.3 (rs11738209, HR=2.36 (95% CI, 1.77 to 3.15), p=4.85×10-9), THSD7A at 7p21.3 (rs2354952, 1.38 (95% CI, 1.24 to 1.55), p=1.61×10-8) and LRP1 at 12q13.3 (rs60565245, 2.18 (95% CI, 1.66 to 2.86), p=2.35×10-8). FGF1 and THSD7A variants were associated with decreased mRNA expression of each gene in iPSC-MNs and reduced in vitro survival of iPSC-MNs obtained from patients with ALS. The iPSC-MN in vitro survival was reduced when the expression of FGF1 and THSD7A was partially disrupted. The rs60565245 was not associated with LRP1 mRNA expression. CONCLUSIONS: We identified three loci associated with the survival of patients with sporadic ALS, decreased mRNA expression of FGF1 and THSD7A and the viability of iPSC-MNs from patients. The iPSC-MN model reflects the association between patient prognosis and genotype and can contribute to target screening and validation for therapeutic intervention. - 神経疾患との鑑別を要したEhlers-Danlos症候群の1例
田中 大貴; 上床 尚; 石川 楓; 山田 一貴; 大嶌 祐貴; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 63, 5, 324, 324, (一社)日本神経学会, 2023年05月
日本語 - 病初期より感覚神経障害を認めた球脊髄性筋萎縮症(SBMA)の1例
石川 楓; 山田 一貴; 大嶌 祐貴; 田中 大貴; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 63, 5, 324, 324, (一社)日本神経学会, 2023年05月
日本語 - 2022年における北海道地区のプリオン病サーベイランスについて
岩田 育子; 阿部 恵; 上床 尚; 白井 慎一; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 63, 5, 326, 326, (一社)日本神経学会, 2023年05月
日本語 - 標準的自己免疫性小脳失調症診療の均てん化を目指す試み
矢口 裕章; 工藤 彰彦; 阿部 恵; 野村 太一; 江口 克紀; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎
臨床神経学, 63, 5, 327, 327, (一社)日本神経学会, 2023年05月
日本語 - 家族性筋萎縮性側索硬化症8の症例
新野 正明; 網野 格; 野村 太一; 長沼 亮滋; 宮崎 雄生; 秋本 幸子; 南 尚哉; 菊地 誠志; 岩田 育子; 宮武 聡子; 松本 直通; 矢部 一郎
臨床神経学, 63, 5, 324, 324, (一社)日本神経学会, 2023年05月
日本語 - 抗GABAB受容体抗体陽性脳炎を合併したLambert-Eaton症候群(LEMS)の1例
山田 一貴; 松島 理明; 石川 楓; 大嶌 祐貴; 田中 大貴; 水島 慶一; 上床 尚; 白井 慎一; 岩田 育子; 矢口 裕章; 田中 惠子; 矢部 一郎
臨床神経学, 63, 5, 326, 326, (一社)日本神経学会, 2023年05月
日本語 - 神経疾患との鑑別を要したEhlers-Danlos症候群の1例
田中 大貴; 上床 尚; 石川 楓; 山田 一貴; 大嶌 祐貴; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 63, 5, 324, 324, (一社)日本神経学会, 2023年05月
日本語 - 病初期より感覚神経障害を認めた球脊髄性筋萎縮症(SBMA)の1例
石川 楓; 山田 一貴; 大嶌 祐貴; 田中 大貴; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 63, 5, 324, 324, (一社)日本神経学会, 2023年05月
日本語 - 抗GABAB受容体抗体陽性脳炎を合併したLambert-Eaton症候群(LEMS)の1例
山田 一貴; 松島 理明; 石川 楓; 大嶌 祐貴; 田中 大貴; 水島 慶一; 上床 尚; 白井 慎一; 岩田 育子; 矢口 裕章; 田中 惠子; 矢部 一郎
臨床神経学, 63, 5, 326, 326, (一社)日本神経学会, 2023年05月
日本語 - 2022年における北海道地区のプリオン病サーベイランスについて
岩田 育子; 阿部 恵; 上床 尚; 白井 慎一; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 63, 5, 326, 326, (一社)日本神経学会, 2023年05月
日本語 - 標準的自己免疫性小脳失調症診療の均てん化を目指す試み
矢口 裕章; 工藤 彰彦; 阿部 恵; 野村 太一; 江口 克紀; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎
臨床神経学, 63, 5, 327, 327, (一社)日本神経学会, 2023年05月
日本語 - Genetic Creutzfeldt‒Jakob disease with 5-octapeptide repeats presented as frontotemporal dementia.
Shinsuke Hamada; Ikuko Takahashi-Iwata; Katsuya Satoh; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Fumio Moriwaka; Ichiro Yabe
Human genome variation, 10, 1, 10, 10, 2023年03月29日, [国際誌]
英語, 研究論文(学術雑誌), The N-terminus of the PRNP gene normally contains a 5-octapeptide repeat (R1-R2-R2-R3-R4), and insertions at this locus can cause hereditary prion diseases. In the present study, we found a 5-octapeptide repeat insertion (5-OPRI) in a sibling case of frontotemporal dementia. Consistent with previous literature, 5-OPRI rarely met the diagnostic criteria for Creutzfeldt‒Jakob disease (CJD). We propose 5-OPRI as a suspected causative mutation for early-onset dementia, especially the frontotemporal type. - Novel Partial Deletions, Frameshift and Missense Mutations of CSF1R in Patents with CSF1R-Related Leukoencephalopathy.
Takanobu Ishiguro; Takuya Konno; Norikazu Hara; Bin Zhu; Satoshi Okada; Mamoru Shibata; Reiko Saika; Takaya Kitano; Megumi Toko; Tomohisa Nezu; Yuka Hama; Tomoya Kawazoe; Ikuko Takahashi-Iwata; Ichiro Yabe; Kota Sato; Hayato Takeda; Shintaro Toda; Jin Nishimiya; Toshiyuki Teduka; Hiroaki Nozaki; Kensaku Kasuga; Akinori Miyashita; Osamu Onodera; Takeshi Ikeuchi
European journal of neurology, 30, 7, 1861, 1870, 2023年03月21日, [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: CSF1R-related leukoencephalopathy is an adult-onset leukoencephalopathy caused by mutations in CSF1R. The present study aimed to explore the broader genetic spectrum of CSF1R-related leukoencephalopathy in association with clinical and imaging features. METHODS: Mutational analysis of CSF1R was performed for 100 consecutive patients with adult-onset leukoencephalopathy. Sequence and copy number variation (CNV) analyses of CSF1R were performed. The genomic ranges of the deletions were determined by long-read sequencing. Ligand-dependent autophosphorylation of CSF1R was examined in cells expressing the CSF1R mutants identified in this study. RESULTS: We identified CSF1R mutations in 15 patients, accounting for 15% of the adult-onset leukoencephalopathy cases. Seven novel and five previously reported CSF1R mutations were identified. The novel mutations, including three missense and one in-frame 3-bp deletion, were located in the tyrosine kinase domain (TKD) of CSF1R. Functional assays revealed that none of the novel mutations in the TKD showed autophosphorylation of CSF1R. We identified two partial deletions of CSF1R that resulted in the lack of the C-terminal region, including the distal TKD, in two patients. Variable clinical features including cognitive impairment, psychiatric symptoms, and gait disturbance were observed. Various degrees of the white matter lesions and corpus callosum abnormalities on MRI and characteristic calcifications on CT were observed as imaging features. CONCLUSIONS: Our results highlighted the importance of examining the CNV of CSF1R even when Sanger or exome sequencing reveal no CSF1R mutations. Genetic examination of sequences and CNV analyses of CSF1R are recommended for an accurate diagnosis of CSF1R-related leukoencephalopathy. - Neutral lipid storage disease with myopathy with a novel homozygous PNPLA2 variant.
Kazuki Yamada; Hiroaki Yaguchi; Megumi Abe; Kaede Ishikawa; Daiki Tanaka; Yuki Oshima; Akihiko Kudo; Hisashi Uwatoko; Shinichi Shirai; Ikuko Takahashi-Iwata; Masaaki Matsushima; Ichizo Nishino; Ichiro Yabe
Clinical neurology and neurosurgery, 228, 107670, 107670, 2023年03月13日, [国際誌]
英語, 研究論文(学術雑誌) - 一過性の好酸球増多によりLoeffler心内膜炎を発症し多発脳梗塞に至った1例
石川 楓; 阿部 恵; 山田 一貴; 大嶌 祐貴; 田中 大貴; 水島 慶一; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 青柳 裕之; 矢部 一郎
臨床神経学, 62, 12, 974, 974, (一社)日本神経学会, 2022年12月
日本語 - MT-TN遺伝子にまれな点変異を認めたミトコンドリア病の1例
田中 大貴; 江口 克紀; 石川 楓; 山田 一貴; 大嶌 祐貴; 水島 慶一; 工藤 彰彦; 阿部 恵; 長井 梓; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 西野 一三; 後藤 雄一; 矢部 一郎
臨床神経学, 62, 12, 975, 975, (一社)日本神経学会, 2022年12月
日本語 - 免疫グロブリン静注療法により筋力改善を認めたSLONM-MGUSの1例
山田 一貴; 上床 尚; 江口 克紀; 石川 楓; 石丸 誠己; 大嶌 祐貴; 田中 大貴; 水島 慶一; 工藤 彰彦; 阿部 恵; 長井 梓; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 西野 一三; 矢部 一郎
臨床神経学, 62, 12, 976, 976, (一社)日本神経学会, 2022年12月
日本語 - 長期経過を追った成人発症アレキサンダー病の1例
大嶌 祐貴; 岩田 育子; 佐藤 翔紀; 石川 楓; 山田 一貴; 田中 大貴; 上床 尚; 白井 慎一; 松島 理明; 原田 太以佑; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 12, 977, 977, (一社)日本神経学会, 2022年12月
日本語 - 非集積地における遺伝性トランスサイレチン型アミロイドーシスの診療経験
松島 理明; 足澤 萌奈美; 野村 太一; 大嶌 祐貴; 芳野 正修; 柴田 有花; 脇田 雅大; 上床 尚; 白井 慎一; 岩田 育子; 矢口 裕章; 矢部 一郎
末梢神経, 33, 2, 355, 355, 日本末梢神経学会, 2022年12月
日本語 - 一過性の好酸球増多によりLoeffler心内膜炎を発症し多発脳梗塞に至った1例
石川 楓; 阿部 恵; 山田 一貴; 大嶌 祐貴; 田中 大貴; 水島 慶一; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 青柳 裕之; 矢部 一郎
臨床神経学, 62, 12, 974, 974, (一社)日本神経学会, 2022年12月
日本語 - MT-TN遺伝子にまれな点変異を認めたミトコンドリア病の1例
田中 大貴; 江口 克紀; 石川 楓; 山田 一貴; 大嶌 祐貴; 水島 慶一; 工藤 彰彦; 阿部 恵; 長井 梓; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 西野 一三; 後藤 雄一; 矢部 一郎
臨床神経学, 62, 12, 975, 975, (一社)日本神経学会, 2022年12月
日本語 - 免疫グロブリン静注療法により筋力改善を認めたSLONM-MGUSの1例
山田 一貴; 上床 尚; 江口 克紀; 石川 楓; 石丸 誠己; 大嶌 祐貴; 田中 大貴; 水島 慶一; 工藤 彰彦; 阿部 恵; 長井 梓; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 西野 一三; 矢部 一郎
臨床神経学, 62, 12, 976, 976, (一社)日本神経学会, 2022年12月
日本語 - 長期経過を追った成人発症アレキサンダー病の1例
大嶌 祐貴; 岩田 育子; 佐藤 翔紀; 石川 楓; 山田 一貴; 田中 大貴; 上床 尚; 白井 慎一; 松島 理明; 原田 太以佑; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 12, 977, 977, (一社)日本神経学会, 2022年12月
日本語 - Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan.
Masaaki Matsushima; Monami Tarisawa; Taichi Nomura; Yuki Oshima; Masanao Yoshino; Yuka Shibata; Masahiro Wakita; Shinichi Shirai; Ikuko Iwata; Hiroaki Yaguchi; Ichiro Yabe
Internal medicine (Tokyo, Japan), 2022年10月19日, [国内誌]
英語, 研究論文(学術雑誌), Objective Hereditary ATTR (ATTRv) amyloidosis was once an incurable disease; however, in recent years, disease-modifying therapies, such as tafamidis and patisiran, have become available. We herein report the medical care situation in an ATTRv amyloidosis non-endemic area of Japan. Methods We confirmed the information in the medical records of our department and analyzed the data retrospectively. Patients Patients with ATTRv amyloidosis who were treated in our department between 2010 and 2021 were included. Results A total of 15 ATTRv amyloidosis cases (8 men and 7 women) were treated in our department during the study period; 9 patients had a family history, and the transthyretin V30M (p.V50M) gene mutation was present in 66% of cases. The average age of the onset was 57 years old, with 73% of the initial symptoms being dysesthesia and 13% being autonomic dysfunction. Ten patients were treated with tafamidis and nine with patisiran. Although it took a long time to start treatment among our experienced cases, there were some cases in which treatment could be introduced relatively early. Conclusion ATTRv amyloidosis is treatable and should be included in the differential diagnosis of neuropathy so that it can be diagnosed early and introduced into treatment. In the near future, the presymptomatic diagnosis of ATTRv amyloidosis and genetic counseling will become more important. - MOG抗体関連脳炎の臨床的特徴の検討
大嶌 祐貴; 山田 一貴; 白井 慎一; 岩田 育子; 金子 仁彦; 高橋 利幸; 田中 惠子; 藤原 一男; 浦 茂久; 矢部 一郎
神経治療学, 39, 6, S254, S254, (一社)日本神経治療学会, 2022年10月
日本語 - 抗ミトコンドリアM2抗体陽性筋炎17例の臨床的特徴
長井 梓; 永井 利幸; 矢口 裕章; 藤井 信太朗; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 堀内 一宏; 浦 茂久; 安斉 俊久; 矢部 一郎
神経治療学, 39, 6, S263, S263, (一社)日本神経治療学会, 2022年10月
日本語 - 帯状疱疹性髄膜脳炎後に血管狭窄が出現し,ステロイド治療が有効であった1例
上床 尚; 大嶌 祐貴; 阿部 恵; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 浦 茂久; 矢部 一郎
NEUROINFECTION, 27, 2, 195, 195, 日本神経感染症学会, 2022年10月
日本語 - 自己免疫性自律神経節障害6症例の長期予後の検討
岩田 育子; 阿部 恵; 上床 尚; 白井 慎一; 松島 理明; 矢口 裕章; 廣谷 真; 中根 俊成; 矢部 一郎
日本自律神経学会総会プログラム・抄録集, 75回, 145, 145, 日本自律神経学会, 2022年10月
日本語 - 抗ミトコンドリアM2抗体陽性筋炎17例の臨床的特徴
長井 梓; 永井 利幸; 矢口 裕章; 藤井 信太朗; 上床 尚; 白井 慎一; 岩田 育子; 松島 理明; 堀内 一宏; 浦 茂久; 安斉 俊久; 矢部 一郎
神経治療学, 39, 6, S263, S263, (一社)日本神経治療学会, 2022年10月
日本語 - MOG抗体関連脳炎の臨床的特徴の検討
大嶌 祐貴; 山田 一貴; 白井 慎一; 岩田 育子; 金子 仁彦; 高橋 利幸; 田中 惠子; 藤原 一男; 浦 茂久; 矢部 一郎
神経治療学, 39, 6, S254, S254, (一社)日本神経治療学会, 2022年10月
日本語 - Clinical features of anti-mitochondrial M2 antibody-positive myositis: case series of 17 patients.
Azusa Nagai; Toshiyuki Nagai; Hiroaki Yaguchi; Shintaro Fujii; Hisashi Uwatoko; Shinichi Shirai; Kazuhiro Horiuchi; Ikuko Iwata; Masaaki Matsushima; Shigehisa Ura; Toshihisa Anzai; Ichiro Yabe
Journal of the neurological sciences, 442, 120391, 120391, 2022年08月28日, [国際誌]
英語, 研究論文(学術雑誌), OBJECTIVE: In 2012, a large number of myositis cases with anti-mitochondrial M2 (AMA-M2) antibody, which had well been known as the serological hallmark for primary biliary cholangitis (PBC), were reported in Japan. Recently, some case series from Japan, France, America, China and India have shown that approximately 2.5% to 19.5% of patients with myositis have AMA-M2 antibody. The objective of this study was to clarify the prevalence, clinical features, treatment outcome, and severity determinants of AMA-M2 positive myositis. METHODS: This study was a multicenter observational study. We enrolled patients who were diagnosed with myositis during a ten-year period between 2012 and 2021. RESULTS: Of the total of 185 patients with inflammatory myopathy, 17 patients were positive for AMA-M2 antibody. The typical symptoms were weakness mainly involving paravertebral muscles, weight loss, respiratory failure, and cardiac complications. Thirteen of the 17 patients had cardiac complications. A strong correlation was found between respiratory failure and modified Rankin Scale (mRS) score. A strong correlation was also found between respiratory failure and body weight, indicating that weight loss can be an indicator of potential progression of respiratory failure. Six of the 17 patients were complicated by malignancy. CONCLUSIONS: This study showed significant correlations between % vital capacity (VC), body mass index (BMI), and mRS score in patients with AMA-M2-positive myositis. Immunotherapy often improved CK level and respiratory dysfunction. We therefore propose that %VC and BMI should be monitored as disease indicators in treatment of AMA-M2-positive myositis. - 胸腺腫摘除術後に発症した重症筋無力症の1例
石丸 誠己; 布村 菫; 穴田 麻眞子; 水島 慶一; 佐藤 翔紀; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 575, 575, (一社)日本神経学会, 2022年07月
日本語 - 北海道地区のプリオン病サーベイランスと否定例の解析
岩田 育子; 阿部 恵; 濱田 晋輔; 白井 慎一; 松島 理明; 矢口 裕章; 森若 文雄; 矢部 一郎
臨床神経学, 62, 7, 576, 576, (一社)日本神経学会, 2022年07月
日本語 - 発症前診断後の継続的支援により早期治療導入に至った遺伝性トランスサイレチン型アミロイドーシス
松島 理明; 柴田 有花; 白井 慎一; 岩田 育子; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 577, 577, (一社)日本神経学会, 2022年07月
日本語 - 神経サルコイドーシスに血管炎による頭蓋内内頸動脈狭窄を伴った1例
穴田 麻眞子; 岩田 育子; 瀬尾 祥; 石丸 誠己; 布村 菫; 水島 慶一; 工藤 彰彦; 佐藤 翔紀; 阿部 恵; 白井 慎一; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 577, 577, (一社)日本神経学会, 2022年07月
日本語 - 世界1例目のSez612抗体陽性小脳性運動失調症の臨床経過
阿部 恵; 矢口 裕章; 長井 梓; 工藤 彰彦; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎
臨床神経学, 62, 7, 577, 577, (一社)日本神経学会, 2022年07月
日本語 - 髄膜増強像を呈した自己免疫性GFAPアストロサイトパチー(GFAP-A)の1例
布村 菫; 水島 慶一; 佐藤 翔紀; 工藤 彰彦; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 578, 578, (一社)日本神経学会, 2022年07月
日本語 - 胸腺腫摘除術後に発症した重症筋無力症の1例
石丸 誠己; 布村 菫; 穴田 麻眞子; 水島 慶一; 佐藤 翔紀; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 575, 575, (一社)日本神経学会, 2022年07月
日本語 - 北海道地区のプリオン病サーベイランスと否定例の解析
岩田 育子; 阿部 恵; 濱田 晋輔; 白井 慎一; 松島 理明; 矢口 裕章; 森若 文雄; 矢部 一郎
臨床神経学, 62, 7, 576, 576, (一社)日本神経学会, 2022年07月
日本語 - 発症前診断後の継続的支援により早期治療導入に至った遺伝性トランスサイレチン型アミロイドーシス
松島 理明; 柴田 有花; 白井 慎一; 岩田 育子; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 577, 577, (一社)日本神経学会, 2022年07月
日本語 - 神経サルコイドーシスに血管炎による頭蓋内内頸動脈狭窄を伴った1例
穴田 麻眞子; 岩田 育子; 瀬尾 祥; 石丸 誠己; 布村 菫; 水島 慶一; 工藤 彰彦; 佐藤 翔紀; 阿部 恵; 白井 慎一; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 577, 577, (一社)日本神経学会, 2022年07月
日本語 - 世界1例目のSez612抗体陽性小脳性運動失調症の臨床経過
阿部 恵; 矢口 裕章; 長井 梓; 工藤 彰彦; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎
臨床神経学, 62, 7, 577, 577, (一社)日本神経学会, 2022年07月
日本語 - 髄膜増強像を呈した自己免疫性GFAPアストロサイトパチー(GFAP-A)の1例
布村 菫; 水島 慶一; 佐藤 翔紀; 工藤 彰彦; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 7, 578, 578, (一社)日本神経学会, 2022年07月
日本語 - Good症候群を背景に小脳及び脳幹に限局する病変を呈した進行性多巣性白質脳症((PML)の1例
布村 菫; 石丸 誠己; 穴田 麻眞子; 水島 慶一; 佐藤 翔紀; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 4, 334, 334, (一社)日本神経学会, 2022年04月
日本語 - 非典型的な症状であるが、seronegative重症筋無力症(SNMG)と考えられた2例
石丸 誠己; 布村 菫; 穴田 麻眞子; 大岩 慧; 水島 慶一; 佐藤 翔紀; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 4, 335, 335, (一社)日本神経学会, 2022年04月
日本語 - Good症候群を背景に小脳及び脳幹に限局する病変を呈した進行性多巣性白質脳症((PML)の1例
布村 菫; 石丸 誠己; 穴田 麻眞子; 水島 慶一; 佐藤 翔紀; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 4, 334, 334, (一社)日本神経学会, 2022年04月
日本語 - 非典型的な症状であるが、seronegative重症筋無力症(SNMG)と考えられた2例
石丸 誠己; 布村 菫; 穴田 麻眞子; 大岩 慧; 水島 慶一; 佐藤 翔紀; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
臨床神経学, 62, 4, 335, 335, (一社)日本神経学会, 2022年04月
日本語 - Anti-myelin oligodendrocyte glycoprotein antibody-associated encephalitis with cortical hyperintensity and pathologically confirmed extensive demyelination
Kosuke Iwami; Ikuko Takahashi-Iwata; Katsuki Eguchi; Azusa Nagai; Shinichi Shirai; Masaaki Matsushima; Hiroaki Yaguchi; Shinichi Nakazato; Satoshi Tanikawa; Yoshiaki Tagawa; Yasuhiro Shinmei; Toshiyuki Takahashi; Shinya Tanaka; Ichiro Yabe
Neuroimmunology Reports, 1, 100032, 100032, Elsevier BV, 2021年12月
研究論文(学術雑誌) - 姿勢推定機械学習モデルを利用した正常圧水頭症患者の歩行ケイデンス定量評価
江口 克紀; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
神経治療学, 38, 6, S276, S276, (一社)日本神経治療学会, 2021年10月
日本語 - 感覚障害を合併し遠位優位の筋力低下を生じた重症筋無力症の1例
工藤 彰彦; 大岩 慧; 白井 慎一; 岩田 育子; 松島 理明; 矢口 裕章; 矢部 一郎
神経治療学, 38, 6, S287, S287, (一社)日本神経治療学会, 2021年10月
日本語 - 免疫介在性小脳性運動失調症における抗Sez6l2抗体の検討
阿部 恵; 矢口 裕章; 長井 梓; 白井 慎一; 岩田 育子; 松島 理明; 芦田 真士; 笠井 高士; 木村 暁夫; 下畑 享良; 矢部 一郎
神経免疫学, 26, 1, 133, 133, (一社)日本神経免疫学会, 2021年10月
日本語 - Progressive multifocal leukoencephalopathy with mild clinical conditions and detection of archetype-like JC virus in cerebrospinal fluid.
Kosuke Iwami; Kazuo Nakamichi; Masaaki Matsushima; Azusa Nagai; Shinichi Shirai; Sho Nakakubo; Ikuko Takahashi-Iwata; Masafumi Yamada; Ichiro Yabe
Journal of neurovirology, 27, 6, 917, 922, 2021年09月22日, [国際誌]
英語, 研究論文(学術雑誌), Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system with a poor prognosis and is primarily caused by JC virus (JCV) with a mutation called prototype. We encountered a case of PML with moderate progression and analyzed the mutational patterns of JCV in the cerebrospinal fluid (CSF). A 19-year-old Japanese woman with mild neurological symptoms was diagnosed with combined immunodeficiency following pneumocystis pneumonia. Brain magnetic resonance imaging scan showed multiple brain lesions, and real-time polymerase chain reaction testing detected JCV in the CSF, leading to the diagnosis of PML. The disease course of PML was stable after administration of mefloquine and mirtazapine with immunoglobulin replacement therapy. In the JCV genome cloned from the patient CSF, DNA sequences of the gene encoding the capsid protein (VP1) and the non-coding control region exhibited small mutations. However, they were quite similar to those of the archetype JCV, which persists asymptomatically in healthy individuals. These findings provide insight into the mutational characteristics of JCV in PML with mild symptoms and progression. - AIDS治療中に脳梗塞で発症し、原因検索に苦慮した中枢神経限局性血管炎の1例
足澤 萌奈美; 江口 克紀; 阿部 恵; 岩田 育子; 松島 理明; 橋本 大吾; 杉山 拓; 矢部 一郎
NEUROINFECTION, 26, 2, 48, 48, 日本神経感染症学会, 2021年09月
日本語 - 非流暢/失文法型原発性進行性失語(naPPA)を呈したPick病
大槻 美佳; 谷川 聖; 中川 賀嗣; 廣谷 真; 江口 克紀; 白井 慎一; 岩田 育子; 松島 理明; 脇田 雅大; 芳野 正修; 大嶌 祐貴; 水島 慶一; 田中 伸哉; 佐々木 秀直; 矢部 一郎
日本神経心理学会総会プログラム・予稿集, 45回, 112, 112, 日本神経心理学会, 2021年09月
日本語 - Lupus-induced autoimmune chloride channelopathy like myotonia congenita, successfully treated with immunosuppression.
Nobuya Abe; Michihito Kono; Ikuko Iwata; Tatsuya Atsumi
Rheumatology (Oxford, England), 61, 1, e4-e5, 2021年08月11日, [国際誌]
英語, 研究論文(学術雑誌) - 高度難聴、視力低下、著明な脳石灰化を主症状としたミトコンドリア病(m.12264C>T)の1例
大岩 慧; 瀬尾 祥; 足澤 萌奈美; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 長沼 亮滋; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 西山 一三; 後藤 雄一
臨床神経学, 61, 7, 502, 502, (一社)日本神経学会, 2021年07月
日本語 - B症状や末梢神経障害を契機に診断された、クリオグロブリン(CG)血管炎の1例
足澤 萌奈美; 大岩 慧; 瀬尾 祥; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 原田 晋平; 遠藤 知之; 矢部 一郎
臨床神経学, 61, 7, 503, 503, (一社)日本神経学会, 2021年07月
日本語 - 大脳皮質脳炎で再発した抗MOG抗体陽性脳炎の1例
田中 大貴; 大岩 慧; 瀬尾 祥; 足澤 萌奈美; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎
臨床神経学, 61, 7, 503, 503, (一社)日本神経学会, 2021年07月
日本語 - Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis.
Hitoshi Aizawa; Haruhisa Kato; Koji Oba; Takuya Kawahara; Yoshihiko Okubo; Tomoko Saito; Makiko Naito; Makoto Urushitani; Akira Tamaoka; Kiyotaka Nakamagoe; Kazuhiro Ishii; Takashi Kanda; Masahisa Katsuno; Naoki Atsuta; Yasushi Maeda; Makiko Nagai; Kazutoshi Nishiyama; Hiroyuki Ishiura; Tatsushi Toda; Akihiro Kawata; Koji Abe; Ichiro Yabe; Ikuko Takahashi-Iwata; Hidenao Sasaki; Hitoshi Warita; Masashi Aoki; Gen Sobue; Hidehiro Mizusawa; Yutaka Matsuyama; Tomohiro Haga; Shin Kwak
Journal of neurology, 269, 2, 885, 896, 2021年06月30日, [国際誌]
英語, 研究論文(学術雑誌), OBJECTIVE: To evaluate the efficacy and safety of perampanel in patients with sporadic amyotrophic lateral sclerosis (SALS). METHODS: This randomized, double-blind, placebo-controlled, multicenter, phase 2 clinical study was conducted at 12 sites. Patients with probable or definite ALS as defined by revised El Escorial criteria were enrolled. Sixty-six patients were randomly assigned (1:1:1) to receive placebo, 4 mg perampanel, or 8 mg perampanel daily for 48 weeks. Adverse events (AEs) were recorded throughout the trial period. The primary efficacy outcome was the change in Amyotrophic Lateral Sclerosis Rating Scale-Revised (ALSFRS-R) score after 48 weeks of treatment. RESULTS: One patient withdrew before starting the treatment. Of 65 patients included, 18 of 22 patients randomized to placebo (82%), 14 of 22 patients randomized to 4 mg perampanel (64%), and 7 of 21 patients randomized to 8 mg perampanel (33%) completed the trial. There was a significant difference in the change of ALSFRS-R scores [- 8.4 (95% CI - 13.9 to - 2.9); p = 0.015] between the placebo and the perampanel 8 mg group, primarily due to worsening of the bulbar subscore in the perampanel 8 mg group. Serious AEs were more frequent in the perampanel 8 mg group than in the placebo group (p = 0.0483). CONCLUSIONS: Perampanel was associated with a significant decline in ALSFRS-R score and was linked to worsening of the bulbar subscore in the 8 mg group. - Inflammatory Myopathy Associated with Anti-mitochondrial Antibody Presenting Only with Respiratory Failure.
Shintaro Fujii; Kazuhiro Horiuchi; Yuki Oshima; Katsuki Eguchi; Azusa Nagai; Ikuko Iwata; Masaaki Matsushima; Ichiro Yabe
Internal medicine (Tokyo, Japan), 60, 23, 3801, 3804, 2021年06月05日, [国内誌]
英語, 研究論文(学術雑誌), A 56-year-old woman presenting with type II respiratory failure was transferred to our hospital. She did not exhibit muscle weakness or elevated serum myogenic enzymes, but needle electromyography revealed myogenic changes in the limb muscles, and her blood tests were positive for anti-mitochondrial antibodies (AMA). Muscle histopathological findings included immune-mediated necrotizing myopathy, so she was diagnosed with inflammatory myopathy associated with AMA. After treatment with corticosteroids and noninvasive positive pressure ventilation, her symptoms improved. If a diagnosis of type II respiratory failure is difficult, inflammatory myopathy associated with AMA should be considered as a differential diagnosis. - Pearls & Oy-sters: Adult-Onset Alexander Disease With Transient Swelling of the Medulla Oblongata.
Yuki Oshima; Ikuko Takahashi-Iwata; Shoki Sato; Taisuke Harada; Tomokatsu Yoshida; Ichiro Yabe
Neurology, 97, 12, 602, 605, 2021年05月26日, [国際誌]
英語, 研究論文(学術雑誌) - 北海道におけるプリオン病サーベイランス状況について
岩田 育子; 濱田 晋輔; 白井 慎一; 松島 理明; 森若 文雄; 矢部 一郎; 佐々木 秀直
臨床神経学, 61, 1, 53, 53, (一社)日本神経学会, 2021年01月
日本語 - 舞踏病を初発症状とした続発性抗リン脂質抗体症候群の1例
藤井 信太朗; 大嶌 祐貴; 堀内 一宏; 岩見 昴亮; 野村 太一; 長井 梓; 江口 克紀; 脇田 雅大; 佐藤 智香; 長沼 亮滋; 白井 慎一; 岩田 育子; 松島 理明; 加藤 将; 矢部 一郎
臨床神経学, 61, 1, 54, 54, (一社)日本神経学会, 2021年01月
日本語 - 長大な脊髄病変を繰り返したBing-Neel症候群の1例
大岩 慧; 瀬尾 祥; 足澤 萌奈美; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 大東 寛幸; 新野 正明
臨床神経学, 61, 1, 54, 54, (一社)日本神経学会, 2021年01月
日本語 - 非定型Logopenic型原発性進行性失語様の言語症状を呈した若年性Alzheimer病の1例
足澤 萌奈美; 大岩 慧; 瀬尾 祥; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 大槻 美佳; 矢部 一郎
臨床神経学, 61, 1, 55, 55, (一社)日本神経学会, 2021年01月
日本語 - Cerebellar Rotation Abnormalities Observed in Machado-Joseph Disease.
Taichi Nomura; Ikuko Iwata; Taisuke Harada; Ichiro Yabe
Internal medicine (Tokyo, Japan), 59, 24, 3253, 3254, 2020年12月15日, [国内誌]
英語, 研究論文(学術雑誌) - A patient with spastic paralysis finally diagnosed as V180I genetic Creutzfeldt-Jakob disease 9 years after onset.
Taichi Nomura; Ikuko Iwata; Ryoji Naganuma; Masaaki Matsushima; Katsuya Satoh; Tetsuyuki Kitamoto; Ichiro Yabe
Prion, 14, 1, 226, 231, 2020年12月, [国際誌]
英語, 研究論文(学術雑誌), Genetic Creutzfeldt-Jakob disease (gCJD) with a mutation in codon 180 of the prion protein gene (V180I gCJD) is the most common form of gCJD in Japan, but only a few cases have been reported in Europe and the United States. It is clinically characterized by occurring in the elderly and presenting as slowly progressive dementia, although it generally shows less cerebellar and pyramidal symptoms than sporadic CJD. Here, we report a patient with V180I gCJD who initially presented with slowly progressive spastic paralysis with neither cerebrospinal fluid (CSF) nor magnetic resonance imaging (MRI) abnormalities. His symptoms progressed gradually, and after 9 years, he displayed features more typical of CJD. Diffusion-weighted MRI revealed high-intensity signals in the cortical gyrus, and there was a marked increase of 14-3-3 protein and total tau protein in the CSF, but he was negative for the real-time quaking-induced conversion assay. Although the time course was more consistent with Gerstmann-Sträussler-Scheinker disease than CJD, genetic testing revealed V180I gCJD. This is the first report of a patient with V180I gCJD who initially presented with spastic paralysis, and also the first to reveal that it took 9 years from disease onset for cortical dysfunction to develop and for MRI and CSF abnormalities to be detectable. In conclusion, we should screen for V180I gCJD in elderly patients presenting with slowly progressive spastic paralysis. - A Retrospective Epidemiological Study of Tick-Borne Encephalitis Virus in Patients with Neurological Disorders in Hokkaido, Japan.
Kentaro Yoshii; Ikuko Takahashi-Iwata; Shinichi Shirai; Shintaro Kobayashi; Ichiro Yabe; Hidenao Sasaki
Microorganisms, 8, 11, 2020年10月28日, [国際誌]
英語, 研究論文(学術雑誌), Tick-borne encephalitis (TBE) is a zoonotic disease that usually presents as a moderate febrile illness followed by severe encephalitis, and various neurological symptoms are observed depending on the distinct central nervous system (CNS) regions affected by the TBE virus (TBEV) infection. In Japan, TBE incidence is increasing and TBEV distributions are reported in wide areas, specifically in Hokkaido. However, an extensive epidemiological survey regarding TBEV has not been conducted yet. In this study, we conducted a retrospective study of the prevalence of antibodies against TBEV in patients with neurological disorders and healthy populations in a TBEV-endemic area in Hokkaido. Among 2000 patients, three patients with inflammatory diseases in the CNS had TBEV-specific IgM antibodies and neutralizing antibodies. The other four patients diagnosed clinically with other neurological diseases were positive for TBEV-specific IgG and neutralizing antibodies, indicating previous TBEV infection. In a total of 246 healthy residents in a TBEV-endemic region, one resident had TBEV-specific antibodies. These results demonstrated undiagnosed TBEV infections in Japan. Further surveys are required to reveal the actual epidemiological risk of TBE and to consider preventive measures, such as a vaccine program, for the control of TBE in Japan. - [A case of tibial nerve palsy due to intraneural ganglion cysts].
Katsuki Eguchi; Shinichi Shirai; Ikuko Iwata; Masaaki Matsushima; Ichiro Yabe
Rinsho shinkeigaku = Clinical neurology, 60, 8, 549, 553, 2020年08月07日, [国内誌]
日本語, 研究論文(学術雑誌), A 39-year-old man presented with an 8-month history of pain and paresthesia of the right foot sole and difficulty in the right toe dorsiflexion. A neurological examination revealed weakness in performing both the ankle and right foot toe dorsiflexion, reduced right planta pedis sensation, and absent right Achilles tendon reflex. Tinel's sign was present on the right popliteal fossa and medial part of the right ankle. MRI of the right knee showed multiple cystic lesions in his right tibial nerve. The cystic lesions extended from the popliteal fossa and were thought to be intraneural ganglion cysts. On MRI performed 4 months later, most of the cystic lesions spontaneously vanished. Therefore, intraneural ganglia should be considered when atypical mononeuropathy, such as tibial nerve palsy, is present. - Constant current stimulation may improve apraxia of eyelid opening induced by deep brain stimulation
Katsuki Eguchi; Ichiro Yabe; Shinichi Shirai; Ikuko Iwata; Masaaki Matsushima; Kazuyoshi Yamazaki; Shuji Hamauchi; Toru Sasamori; Toshitaka Seki; Kiyohiro Houkin; Hidenao Sasaki
Interdisciplinary Neurosurgery, 19, 100565, 100565, Elsevier {BV}, 2020年03月
英語, 研究論文(学術雑誌) - MM2 cortical form of sporadic Creutzfeldt-Jakob disease without progressive dementia and akinetic mutism: A case deviating from current diagnostic criteria.
Ikuko Takahashi-Iwata; Ichiro Yabe; Akihiko Kudo; Katsuya Eguchi; Masahiro Wakita; Shinichi Shirai; Masaaki Matsushima; Takanobu Toyoshima; Susumu Chiba; Satoshi Tanikawa; Shinya Tanaka; Katsuya Satoh; Tetsuyuki Kitamoto; Hidenao Sasaki
Journal of the neurological sciences, 412, 116759, 116759, 2020年02月24日, [査読有り], [国際誌]
英語 - Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease.
Ryoji Naganuma; Ichiro Yabe; Megumi Takeuchi; Kirari Morishita; Shingo Nakane; Ryoken Takase; Ikuko Takahashi-Iwata; Masaaki Matsushima; Mika Otsuki; Hideaki Shiraishi; Hidenao Sasaki
PloS one, 15, 9, e0232808, 2020年, [国際誌]
英語, 研究論文(学術雑誌), Studies on evoked responses in Parkinson's disease (PD) may be useful for elucidating the etiology and quantitative evaluation of PD. However, in previous studies, the association between evoked responses and detailed motor symptoms or cognitive functions has not been clear. This study investigated the characteristics of the visual (VEF), auditory (AEF), and somatosensory (SEF) evoked magnetic fields in patients with Parkinson's disease (PD), and the correlations between evoked fields and the patient's clinical characteristics, motor symptoms, and cognitive functions. Twenty patients with PD and 10 healthy controls (HCs) were recruited as participants. We recorded VEF, AEF, and SEF, collected clinical characteristics, performed physical examinations, and administered 10 cognitive tests. We investigated differences in the latencies of the evoked fields between patients with PD and HCs. We also evaluated the correlation of the latencies with motor symptoms and cognitive functioning. There were significant differences between the two groups in 6 of the cognitive tests, all of which suggested mild cognitive impairment in patients with PD. The latencies of the VEF N75m, P100m, N145m, AEF P50m, P100m, and SEF P60m components were greater in the patients with PD than in the HCs. The latencies mainly correlated with medication and motor symptoms, less so with cognitive tests, with some elements of the correlations remaining significant after Bonferroni correction. In conclusion, the latencies of the VEF, AEF, and SEF were greater in PD patients than in HCs and were mainly correlated with medication and motor symptoms rather than cognitive functioning. Findings from this study suggest that evoked fields may reflect basal ganglia functioning and are candidates for assessing motor symptoms or the therapeutic effects of medication in patients with PD. - Emery-Dreifuss型筋ジストロフィー(EDMD)の1例
藤井 信太朗; 岩見 昴亮; 野村 太一; 高橋 俊樹; 長井 梓; 江口 克紀; 脇田 雅大; 佐藤 智香; 長沼 亮滋; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 藤田 篤史; 西野 一三
臨床神経学, 60, 1, 92, 92, (一社)日本神経学会, 2020年01月, [査読有り]
日本語 - The neural circuit linking mushroom body parallel circuits induces memory consolidation in Drosophila.
Hiroko Awata; Mai Takakura; Yoko Kimura; Ikuko Iwata; Tomoko Masuda; Yukinori Hirano
Proceedings of the National Academy of Sciences of the United States of America, 116, 32, 16080, 16085, 2019年08月06日, [国際誌]
英語, 研究論文(学術雑誌), Memory consolidation is augmented by repeated learning following rest intervals, which is known as the spacing effect. Although the spacing effect has been associated with cumulative cellular responses in the neurons engaged in memory, here, we report the neural circuit-based mechanism for generating the spacing effect in the memory-related mushroom body (MB) parallel circuits in Drosophila To investigate the neurons activated during the training, we monitored expression of phosphorylation of mitogen-activated protein kinase (MAPK), ERK [phosphorylation of extracellular signal-related kinase (pERK)]. In an olfactory spaced training paradigm, pERK expression in one of the parallel circuits, consisting of γm neurons, was progressively inhibited via dopamine. This inhibition resulted in reduced pERK expression in a postsynaptic GABAergic neuron that, in turn, led to an increase in pERK expression in a dopaminergic neuron specifically in the later session during spaced training, suggesting that disinhibition of the dopaminergic neuron occurs during spaced training. The dopaminergic neuron was significant for gene expression in the different MB parallel circuits consisting of α/βs neurons for memory consolidation. Our results suggest that the spacing effect-generating neurons and the neurons engaged in memory reside in the distinct MB parallel circuits and that the spacing effect can be a consequence of evolved neural circuit architecture. - The Responsiveness of Triaxial Accelerometer Measurement of Gait Ataxia Is Higher than That of the Scale for the Assessment and Rating of Ataxia in the Early Stages of Spinocerebellar Degeneration.
Shirai S; Yabe I; Takahashi-Iwata I; Matsushima M; Ito YM; Takakusaki K; Sasaki H
Cerebellum (London, England), 18, 4, 721, 730, 2019年08月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), We reported previously that the average medial-lateral gait amplitude while walking on a straight path determined using triaxial accelerometers fixed on the middle of the upper back may be a quantitative and concise indicator for the severity of cerebellar ataxia. Considering that gait ataxia is a typical initial symptom in a variety of spinocerebellar degeneration (SCD), we aimed to develop quantitative biomarkers for cerebellar ataxia as metric variables. We used triaxial accelerometers to analyze gait parameters in 14 patients with SCD at 3 points over 3 years (at baseline, 1.5 years and 3 years). Analysis of covariance (ANCOVA) models adjusted for the baseline scores were used to estimate sample sizes. The mean medial-lateral amplitude (ML) gained by a triaxial accelerometer fixed on upper back could detect the each 1.5-year change. In the 14 patients, the mean ML(m) was 0.032 ± 0.007(SD) at entry, 0.037 ± 0.008 after 1.5-year follow, and 0.042 ± 0.020 after 3-year follow. In contrast, SARA gait scores were 2.9, 2.9, and 3.0, respectively. The responsiveness of the quantitative evaluation of gait ataxia by triaxial accelerometers is higher than that of the SARA within a 1.5-year follow-up period. Gait analysis by triaxial accelerometers will be complementary to the evaluation of scales like SARA in the assessment of clinical severity of SCD patients in early stage. - Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Molecular brain, 12, 1, 49, 49, 2019年05月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), MicroRNAs (miRNAs) are endogenous small (18-25 nt), single-stranded, non-coding RNAs that play key roles in post-transcriptional gene expression regulation. The expression profiles of miRNAs in biofluids and tissues change in various diseases. Multiple system atrophy (MSA) and Parkinson's disease (PD) are both categorized as α-synucleinopathies and often present with similar clinical manifestations. This study aimed to identify miRNAs that are differently expressed in plasma samples of PD patients, MSA patients, and healthy controls. We used microarray analysis to screen for miRNAs that are up- and down-regulated in these patients and analyzed the relative-quantitative expression levels of the identified miRNAs by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Hsa-miR-671-5p, hsa-miR-19b-3p, and hsa-miR-24-3p showed significantly different expression levels among patients with MSA-C, MSA-P, or PD, and healthy controls. Hsa-miR-671-5p levels were lower in the MSA-P and PD than the MSA-C and control groups, hsa-miR-19b-3p levels were higher in the PD than the other groups, and hsa-miR-24-3p levels were higher in the PD than the MSA-C group. Hsa-miR-671-5p was the first miRNA shown to be expressed differently between MSA-C and MSA-P in plasma. Interestingly, the expression levels of hsa-miR-19b-3p and hsa-miR-24-3p were positively correlated, indicating that these miRNAs may be involved in the same processes in PD pathogenesis. Our findings suggest that hsa-miR-671-5p, hsa-miR-19b-3p, and hsa-miR-24-3p may reflect the pathophysiology or symptoms of PD and MSA. - Genome-wide DNA methylation analysis of multiple system atrophy (MSA): a study of nuclear families and monozygotic twins discordant for MSA
Hama Y; Yabe I; Matsushima M; Takahashi I; Hisanaga K; Ogata A; Katsu M; Kato T; Utsumi J; Sasaki H
BMC Neurology, 2019年, [査読有り] - Hashimoto's encephalopathy mimicking a brain tumor and its pathological findings: A case report.
Hisashi Uwatoko; Ichiro Yabe; Shoki Sato; Megumi Abe; Shinichi Shirai; Ikuko Takahashi; Masaaki Matsushima; Takahiro Kano; Shigeru Yamaguchi; Kanako C Hatanaka; Makoto Yoneda; Hidenao Sasaki
Journal of the neurological sciences, 394, 141, 143, 2018年11月15日, [査読有り], [国際誌]
英語, Hashimoto's encephalopathy is characterized by the presence of anti-thyroid antibodies with no alternative cause. Patients with Hashimoto's encephalopathy present with various clinical symptoms and magnetic resonance imaging (MRI) findings. To our knowledge, this is the first documented report of Hashimoto's encephalopathy with MRI findings mimicking a brain tumor. The patient was a 41-year-old woman with a history of Hashimoto's disease. She experienced gradually worsening Parkinsonism and an MRI revealed a brain tumor-like lesion at the left caudate nucleus. She underwent a brain biopsy that revealed diffuse gliosis and perivascular lymphocyte infiltration with CD3+ T-cell predominance. No pathological signs of a brain tumor were found. Hashimoto's encephalopathy was suspected based on the patient's history and the presence of anti-thyroid antibodies. Her symptoms and the MRI findings improved with glucocorticoid treatment. Although there exist only a few studies on the pathology of Hashimoto's encephalopathy, our findings were consistent with those of previous reports. Our findings suggest cerebral vasculitis as an underlying etiology of Hashimoto's encephalopathy. We also emphasize the importance of considering Hashimoto's encephalopathy as a differential diagnosis of brain tumors. - Tremor during orthostatism as the initial symptom of Machado-Joseph disease.
Shirai S; Yabe I; Naganuma R; Sato C; Takahashi I; Matsushima M; Kano T; Sasaki H
Clinical neurology and neurosurgery, 173, 173, 175, 2018年10月, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), A 60-year-old man was admitted to our hospital. He had mild tremor in his four extremities when supine or sitting, which was markedly exacerbated when standing. We diagnosed him with Machado-Joseph disease according to the genetic test. His tremor improved with clonazepam, trihexyphenidyl, and a rotigotine patch. - Long-Term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients
Takeya Kitta; Ichiro Yabe; Yukiko Kanno; Madoka Higuchi; Mifuka Ouchi; Mio Togo; Kimihiko Moriya; Ikuko Takahashi; Masaaki Matsushima; Hidenao Sasaki; Nobuo Shinohara
Clinical Neuropharmacology, 41, 3, 98, 102, Lippincott Williams and Wilkins, 2018年05月01日, [査読有り]
英語, 研究論文(学術雑誌) - Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome.
Ichiro Yabe; Hiroaki Yaguchi; Yasutaka Kato; Yasuo Miki; Hidehisa Takahashi; Satoshi Tanikawa; Shinichi Shirai; Ikuko Takahashi; Mari Kimura; Yuka Hama; Masaaki Matsushima; Shinsuke Fujioka; Takahiro Kano; Masashi Watanabe; Shin Nakagawa; Yasuyuki Kunieda; Yoshio Ikeda; Masato Hasegawa; Hiroshi Nishihara; Toshihisa Ohtsuka; Shinya Tanaka; Yoshio Tsuboi; Shigetsugu Hatakeyama; Koichi Wakabayashi; Hidenao Sasaki
Scientific reports, 8, 1, 819, 819, 2018年01月16日, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), Clinical diagnosis of progressive supranuclear palsy (PSP) is sometimes difficult because various phenotypes have been identified. Here, we report a mutation in the bassoon (BSN) gene in a family with PSP-like syndrome. Their clinical features resembled not only those of PSP patients but also those of individuals with multiple system atrophy and Alzheimer's disease. The neuropathological findings showed a novel three + four repeat tauopathy with pallido-luysio-nigral degeneration and hippocampal sclerosis. Whole-exome analysis of this family identified a novel missense mutation in BSN. Within the pedigree, the detected BSN mutation was found only in affected individuals. Further genetic analyses were conducted in probands from four other pedigrees with PSP-like syndrome and in 41 sporadic cases. Three missense mutations in BSN that are very rarely listed in databases of healthy subjects were found in four sporadic cases. Western blot analysis of tau following the overexpression of wild-type or mutated BSN revealed the possibility that wild-type BSN reduced tau accumulation, while mutated BSN lost this function. An association between BSN and neurological diseases has not been previously reported. Our results revealed that the neurodegenerative disorder associated with the original proband's pedigree is a novel tauopathy, differing from known dementia and parkinsonism syndromes, including PSP. - A retrospective study of the effects of 3,4-diaminopyridine treatment in Lambert-Eaton myasthenic syndrome
Ryoji Naganuma; Ichiro Yabe; Ikuko Takahashi; Masaaki Matsushima; Takahiro Kano; Hidenao Sasaki
Clinical Neurology, 58, 2, 83, 87, Societas Neurologica Japonica, 2018年, [査読有り]
日本語, 研究論文(学術雑誌) - The Efficacy of Istradefylline for Treating Mild Wearing-Off in Parkinson Disease
Ichiro Yabe; Mayumi Kitagawa; Ikuko Takahashi; Masaaki Matsushima; Hidenao Sasaki
CLINICAL NEUROPHARMACOLOGY, 40, 6, 261, 263, 2017年11月, [査読有り]
英語 - Genomic copy number variation analysis in multiple system atrophy
Yuka Hama; Masataka Katsu; Ichigaku Takigawa; Ichiro Yabe; Masaaki Matsushima; Ikuko Takahashi; Takayuki Katayama; Jun Utsumi; Hidenao Sasaki
MOLECULAR BRAIN, 10, 1, 54, 2017年11月, [査読有り]
英語, 研究論文(学術雑誌) - The Letter to be published with the Letter, Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case report
Hiroaki Yaguchi; Akiko Takeuchi; Kazuhiro Horiuchi; Ikuko Takahashi; Shinnichi Shirai; Sachiko Akimoto; Katsuya Satoh; Fumio Moriwaka; Ichiro Yabe; Ichiro Yabe
JOURNAL OF THE NEUROLOGICAL SCIENCES, 375, 490, 491, 2017年04月, [査読有り]
英語 - Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case
Hiroaki Yaguchi; Akiko Takeuchi; Kazuhiro Horiuchi; Ikuko Takahashi; Shinnichi Shirai; Sachiko Akimoto; Katsuya Satoh; Fumio Moriwaka; Ichiro Yabe; Hidenao Sasaki
JOURNAL OF THE NEUROLOGICAL SCIENCES, 372, 444, 446, 2017年01月, [査読有り]
英語 - Validity and reliability of a pilot scale for assessment of multiple system atrophy symptoms.
Matsushima M; Yabe I; Takahashi I; Hirotani M; Kano T; Horiuchi K; Houzen H; Sasaki H
Cerebellum & ataxias, 4, 11, 11, 2017年, [査読有り], [国際誌]
英語, 研究論文(学術雑誌), BACKGROUND: Multiple system atrophy (MSA) is a rare progressive neurodegenerative disorder for which brief yet sensitive scale is required in order for use in clinical trials and general screening. We previously compared several scales for the assessment of MSA symptoms and devised an eight-item pilot scale with large standardized response mean [handwriting, finger taps, transfers, standing with feet together, turning trunk, turning 360°, gait, body sway]. The aim of the present study is to investigate the validity and reliability of a simple pilot scale for assessment of multiple system atrophy symptoms. METHODS: Thirty-two patients with MSA (15 male/17 female; 20 cerebellar subtype [MSA-C]/12 parkinsonian subtype [MSA-P]) were prospectively registered between January 1, 2014 and February 28, 2015. Patients were evaluated by two independent raters using the Unified MSA Rating Scale (UMSARS), Scale for Assessment and Rating of Ataxia (SARA), and the pilot scale. Correlations between UMSARS, SARA, pilot scale scores, intraclass correlation coefficients (ICCs), and Cronbach's alpha coefficients were calculated. RESULTS: Pilot scale scores significantly correlated with scores for UMSARS Parts I, II, and IV as well as with SARA scores. Intra-rater and inter-rater ICCs and Cronbach's alpha coefficients remained high (> 0.94) for all measures. CONCLUSION: The results of the present study indicate the validity and reliability of the eight-item pilot scale, particularly for the assessment of symptoms in patients with early state multiple system atrophy. - Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson's disease
Takeya Kitta; Ichiro Yabe; Ikuko Takahashi; Masaaki Matsushima; Hidenao Sasaki; Nobuo Shinohara
INTERNATIONAL JOURNAL OF UROLOGY, 23, 10, 893, 894, 2016年10月, [査読有り]
英語 - Pseudodystonia in sarcoid myopathy.
Uwatoko, H; Yabe, I; Shirai, S; Takahashi, I; Matsushima, M; Kano, T; Sasaki, H
Neurology and Clinical Neuroscience, 4, 1, 34, 35, 2016年08月, [査読有り]
英語, 研究論文(学術雑誌) - Frontotemporal dementia and progressive supranuclear palsy‐like syndrome with a novel TARDBP mutation.
Yabe, I; Nakano, F; Shirai, S; Matsushima, M; Takahashi, I; Sasaki, H
Neurology and Clinical Neuroscience, 4, 2, 76, 77, 2016年01月, [査読有り]
英語, 研究論文(学術雑誌) - An SCA14 family with a novel PRKCG mutation.
Yabe I; Kimura M; Shirai S; Takahashi I; Matsushima M; Sasaki H
Neurology Clin Neurosci, 4, 199, 200, 2016年, [査読有り]
英語, 研究論文(学術雑誌) - Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis
Ikuko Takahashi; Yuka Hama; Masaaki Matsushima; Makoto Hirotani; Takahiro Kano; Hideki Hohzen; Ichiro Yabe; Jun Utsumi; Hidenao Sasaki
MOLECULAR BRAIN, 8, 1, 67, 2015年10月, [査読有り]
英語, 研究論文(学術雑誌) - Rare frequency of downbeat positioning nystagmus in spinocerebellar ataxia type 31
Ichiro Yabe; Masaaki Matsushima; Kunihiro Yoshida; Kinya Ishikawa; Shinichi Shirai; Ikuko Takahashi; Hidenao Sasaki
JOURNAL OF THE NEUROLOGICAL SCIENCES, 350, 1-2, 90, 92, 2015年03月, [査読有り]
英語, 研究論文(学術雑誌) - A case of anti-PL7 antibody positive myositis and a clinical and pathological review of the anti-synthetase syndrome
Masaaki Matsushima; Yuka Shimizu; Ikuko Takahashi; Kazunori Sato; Makoto Hirotani; Takahiro Kano; Ichiro Yabe; Hidenao Sasaki
Clinical Neurology, 55, 11, 810, 815, Societas Neurologica Japonica, 2015年, [査読有り]
日本語 - Usefulness of C-11-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy
Shinichi Shirai; Ichiro Yabe; Takahiro Kano; Yuka Shimizu; Toru Sasamori; Kazunori Sato; Makoto Hirotani; Takayuki Nonaka; Ikuko Takahashi; Masaaki Matsushima; Naoya Minami; Kazuo Nakamichi; Masayuki Saijo; Kanako C. Hatanaka; Tohru Shiga; Shinya Tanaka; Hidenao Sasaki
JOURNAL OF NEUROLOGY, 261, 12, 2314, 2318, 2014年12月, [査読有り]
英語, 研究論文(学術雑誌) - Pathology of frontotemporal dementia with limb girdle muscular dystrophy caused by a DNAJB6 mutation
Ichiro Yabe; Mishie Tanino; Hiroaki Yaguchi; Akihiro Takiyama; Huaying Cai; Hiromi Kanno; Ikuko Takahashi; Yukiko K. Hayashi; Masashi Watanabe; Hidehisa Takahashi; Shigetsugu Hatakeyama; Shinya Tanak; Hidenao Sasaki
CLINICAL NEUROLOGY AND NEUROSURGERY, 127, 10, 12, 2014年12月, [査読有り]
英語, 研究論文(学術雑誌) - Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder
Hiroaki Yaguchi; Ken Sakushima; Ikuko Takahashi; Hiroaki Nishimura; Moemi Yashima-Yamada; Masakazu Nakamura; Kazufumi Tsuzaka; Yasunori Maruo; Toshiyuki Takahashi; Ichiro Yabe; Hidenao Sasaki
Internal Medicine, 52, 9, 969, 972, 2013年05月01日, [査読有り]
英語, 研究論文(学術雑誌) - Treatment of intractable tuberculous meningitis using intrathecal isoniazid administration and steroid pulse therapy; A report of two cases
Ikuko Takahashi; Moemi Yamada; Masaaki Matsushima; Kazunori Sato; Takahiro Kano; Ichiro Yabe; Hidenao Sasaki
Clinical Neurology, 52, 8, 551, 556, 2012年08月, [査読有り]
日本語, 研究論文(学術雑誌) - A case of intravascular lymphoma with a longitudinal spinal lesion diagnosed by multiple biopsies
Shinichi Shirai; Ikuko Takahashi; Takahiro Kanoh; Kazunori Sato; Kanako C. Kubota; Ichiro Yabe; Shigeo Murayama; Hidenao Sasaki
Clinical Neurology, 52, 5, 336, 343, 2012年05月, [査読有り]
日本語, 研究論文(学術雑誌) - A case of posterior reversible encephalopathy syndrome occurring after anemia correction
Masaaki Matsushima; Ikuko Takahashi; Hideki Houzen
Clinical Neurology, 52, 3, 147, 151, 2012年03月, [査読有り]
日本語, 研究論文(学術雑誌) - A case of successful treatment of brain and lung cryptococcosis caused by Cryptococcus gattii
Kazuhiro Horiuchi; Moemi Yamada; Shinichi Shirai; Ikuko Takahashi; Takahiro Kano; Yukihiro Kaneko; Kouji Akizawa; Takashi Umeyama; Yoshitsugu Miyazaki; Ichiro Yabe; Hidenao Sasaki
Clinical Neurology, 52, 3, 166, 171, 2012年03月, [査読有り]
日本語, 研究論文(学術雑誌) - Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC 0-1band trough levels
Akiko Takeuchi; Shinichi Shirai; Kazuhiro Horiuchi; Ikuko Takahashi; Masaaki Matsushima; Makoto Hirotani; Takahiro Kano; Ichiro Yabe; Akihisa Matumoto; Hidenao Sasaki
Clinical Neurology, 52, 3, 172, 177, 2012年03月, [査読有り]
日本語, 研究論文(学術雑誌) - 慢性炎症性脱髄性多発神経炎に対するシクロスポリンAの至適用量設定に関するトラフ値、血中濃度下面積測定の有用性
廣谷真; 竹内朗子; 白井慎一; 堀内一宏; 高橋育子; 松島理明; 加納崇裕; 矢部一郎; 松本昭久; 佐々木秀直
末梢神経, 28, 231, 232, 2012年, [査読有り] - Progressive anterior operculum syndrome due to FTLD-TDP: a clinico-pathological investigation
Mika Otsuki; Yoshitsugu Nakagawa; Fumiaki Mori; Hirotoshi Tobioka; Hideaki Yoshida; Yoshiharu Tatezawa; Toshio Tanigawa; Ikuko Takahashi; Ichiro Yabe; Hidenao Sasaki; Koichi Wakabayashi
JOURNAL OF NEUROLOGY, 257, 7, 1148, 1153, 2010年07月, [査読有り]
英語, 研究論文(学術雑誌) - Scapular winging as a symptom of cervical flexion myelopathy
Hiroaki Yaguchi; Ikuko Takahashi; Jun Tashiro; Sachiko Tsuji; Ichiro Yabe; Hidenao Sasaki
INTERNAL MEDICINE, 46, 8, 511, 513, 2007年, [査読有り]
英語, 研究論文(学術雑誌)
- レビー小体病と筋萎縮性側索硬化症を合併した1剖検例
篠森 由貴; 白井 裕介; 小田 義崇; 種井 善一; 岩田 育子; 杉野 弘和; 津田 真寿美; 矢部 一郎; 田中 伸哉, 日本病理学会会誌, 115, 1, 522, 522, 2026年03月
(一社)日本病理学会, 日本語 - レビー小体病と筋萎縮性側索硬化症を合併した1剖検例
篠森 由貴; 白井 裕介; 小田 義崇; 種井 善一; 岩田 育子; 杉野 弘和; 津田 真寿美; 矢部 一郎; 田中 伸哉, 日本病理学会会誌, 115, 1, 522, 522, 2026年03月
(一社)日本病理学会, 日本語 - 筋萎縮性側索硬化症患者の発症年齢に関連する新規遺伝的因子の同定
中村 亮一; 藤内 玄規; 熱田 直樹; 松田 侑美; 森本 悟; 伊藤 大輔; 勝野 雅央; 和泉 唯信; 森田 光哉; 岩田 育子; 矢部 一郎; 服部 信孝; 平山 剛久; 狩野 修; 鈴木 直輝; 青木 正志; 道勇 学; 岡野 栄之; 中杤 昌弘; 祖父江 元, 臨床神経学, 65, Suppl., S235, S235, 2025年09月
(一社)日本神経学会, 日本語 - Vogt-小柳-原田病における脳脊髄液所見の検討
上床尚; 足澤萌奈美; 野村太一; 藤井信太朗; 田中大貴; 工藤彰彦; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 南場研一; 石田晋; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 66th, 2025年 - 非流暢/失文法型原発性進行性失語(naPPA)の下位分類とその症候
大槻美佳; 中川賀嗣; 輿水修一; 緒方昭彦; 新保和賢; 水戸泰紀; 田島康敬; 濱田晋輔; 浦茂久; 金藤公人; 保前英希; 赤池瞬; 岩田育子; 松島理明; 矢口裕章; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 65th, 2024年 - 乾燥症状を伴わずに多彩な神経症状で発症したSjoegren症候群の1例
井上貴司; 布村菫; 足澤萌奈美; 藤井信太朗; 野村太一; 上床尚; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 津坂和文; 小池春樹; 矢部一郎, 臨床神経学(Web), 64, 6, 2024年 - 筋力低下を伴わない高CKの血症を呈したカルパイノパチーの1例
藤井信太朗; 野村太一; 上床尚; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 斎藤良彦; 西野一三; 矢部一郎, 臨床神経学(Web), 64, 6, 2024年 - 血清VEGF値の陽転化で診断に至ったPOEMS症候群の1例
野村太一; 岩田育子; 江口克紀; 井上貴司; 足澤萌奈美; 藤井信太朗; 田中大貴; 上床尚; 白井慎一; 松島理明; 矢口裕章; 矢部一郎, 臨床神経学(Web), 64, 6, 2024年 - 北海道地区のプリオン病サーベイランスと非定型的gCJD
岩田育子; 阿部恵; 濱田普輔; 白井慎一; 松島理明; 矢口裕章; 江口克紀; 森若文雄; 矢部一郎, 臨床神経学(Web), 64, 6, 2024年 - 急速進行性の末梢神経障害が主症状であったSCA2の1例
芳野正修; 岩見昂亮; 武石侑杜; 穴田麻眞子; 藤井信太朗; 野村太一; 足澤萌奈美; 上床尚; 白井慎一; 松島理明; 岩田育子; 矢口裕章; 小池春樹; 矢部一郎, 臨床神経学(Web), 64, 11, 2024年 - Tumefactive demyelinating lesionと鑑別を要した膠芽腫の1例
武石侑杜; 上床尚; 穴田麻眞子; 岩見昂亮; 芳野正修; 野村太一; 藤井信太朗; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 白井東磨; 伊師雪友; 山口秀; 若林健人; 外丸詩野; 深澤俊行; 矢部一郎, 臨床神経学(Web), 64, 11, 2024年 - 右利きで右半球の障害による発語失行を呈した大脳皮質基底核症候群の1例
岩見昂亮; 上床尚; 藤井信太朗; 赤池瞬; 穴田麻眞子; 武石侑杜; 芳野正修; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 大槻美佳; 矢部一郎, 臨床神経学(Web), 64, 11, 2024年 - 大学病院における多診療科連携型軽度認知障害センターの構築
岩田育子; 松島理明; 宇土仁木; 池辺洋平; 平田健司; 杉山拓; 森田真也; 渡邊裕; 向野雅彦; 中村昭伸; 佐久嶋研; 熊谷聡美; 藤村幹; 工藤與亮; 矢部一郎, Dementia Japan, 38, 4, 681, 681, 2024年
(一社)日本認知症学会, 日本語 - もやもや病のエピゲノム病態修飾因子探索
伊東雅基; 内野晴登; 東海林菊太郎; 杉山拓; 川堀真人; 岩田育子; 矢部一郎; 寶金清博; 藤村幹, 月刊メディカル・サイエンス・ダイジェスト, 50, 6, 2024年 - CSF1R関連白質脳症 部分欠失を含む新規CSF1R変異の同定と臨床・画像的特徴
石黒 敬信; 今野 卓哉; 原 範和; 朱 斌; 岡田 聡; 柴田 護; 雑賀 玲子; 北野 貴也; 祢津 智久; 濱 由香; 川添 僚也; 岩田 育子; 佐藤 恒太; 春日 健作; 宮下 哲典; 小野寺 理; 池内 健, 臨床神経学, 63, Suppl., S291, S291, 2023年09月
(一社)日本神経学会, 日本語 - 中枢神経感染症の診断と治療に対する髄液多項目核酸検査の効果
岩田育子; 上床尚; 白井慎一; 松島理明; 矢口裕章; 石黒信久; 豊嶋崇徳; 矢部一郎, Neuroinfection (Web), 28, 2, 2023年 - 神経変性疾患領域の基盤的調査研究 本態性振戦(重症)に関する研究
古和久典; 有村公良; 安藤利奈; 岩田育子; 押野悟; 貴島晴彦; 小島原典子; 小仲邦; 小仲邦; 白井慎一; 田代淳; 永井将弘; 中島健二; 中村雄作; 西川典子; 服部憲明; 馬場孝輔; 松島理明; 目崎高広; 望月秀樹; 矢部一郎, 神経変性疾患領域の基盤的調査研究 令和4年度 総括・分担研究報告書(Web), 2023年 - 標準的自己免疫性小脳失調症診療の均てん化を目指す試み
矢口裕章; 工藤彰彦; 阿部恵; 野村太一; 江口克紀; 上床尚; 白井慎一; 岩田育子; 松島理明; 矢部一郎, 臨床神経学(Web), 63, 5, 2023年 - 視神経乳頭炎で発症し,髄膜脳炎症状が軽微であった自己免疫性GFAPアストロサイトパチー(GFAP-A)の1例
藤井信太朗; 井上貴司; 足澤萌奈美; 野村太一; 田中大貴; 水島慶一; 工藤彰彦; 阿部恵; 上床尚; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 荻野陽; 矢部一郎, 臨床神経学(Web), 63, 11, 2023年 - 髄膜増強像を呈した自己免疫性GFAPアストロサイトパチー(GFAP-A)の1例
布村菫; 水島慶一; 佐藤翔紀; 工藤彰彦; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 矢部一郎, 臨床神経学(Web), 62, 7, 2022年 - 神経サルコイドーシスに血管炎による頭蓋内内頚動脈狭窄を伴った1例
穴田麻眞子; 岩田育子; 瀬尾祥; 石丸誠己; 布村菫; 水島慶一; 工藤彰彦; 佐藤翔紀; 阿部恵; 白井慎一; 松島理明; 矢口裕章; 矢部一郎, 臨床神経学(Web), 62, 7, 2022年 - 世界1例目のSez612抗体陽性小脳性運動失調症の臨床経過
阿部恵; 矢口裕章; 長井梓; 工藤彰彦; 白井慎一; 岩田育子; 松島理明; 矢部一郎, 臨床神経学(Web), 62, 7, 2022年 - MT-TN遺伝子にまれな点変異を認めたミトコンドリア病の1例
田中大貴; 江口克紀; 江口克紀; 石川楓; 山田一貴; 大嶌祐貴; 水島慶一; 工藤彰彦; 阿部恵; 長井梓; 上床尚; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 西野一三; 後藤雄一; 矢部一郎, 臨床神経学(Web), 62, 12, 2022年 - 免疫グロブリン静注療法により筋力改善を認めたSLONM-MGUSの1例
山田一貴; 上床尚; 江口克紀; 石川楓; 石丸誠己; 大嶌祐貴; 田中大貴; 水島慶一; 工藤彰彦; 阿部恵; 長井梓; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 西野一三; 矢部一郎, 臨床神経学(Web), 62, 12, 2022年 - 非典型的な症状であるが,seronegative重症筋無力症(SNMG)と考えられた2例
石丸誠己; 布村菫; 穴田麻眞子; 大岩慧; 水島慶一; 佐藤翔紀; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 矢部一郎, 臨床神経学(Web), 62, 4, 2022年 - Good症候群を背景に小脳及び脳幹に限局する病変を呈した進行性多巣性白質脳症(PML)の1例
布村菫; 石丸誠己; 穴田麻眞子; 水島慶一; 佐藤翔紀; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 矢部一郎, 臨床神経学(Web), 62, 4, 2022年 - 非HIV関連かつ免疫抑制剤を使用していない進行性多巣性白質脳症5例の臨床的検討
穴田麻眞子; 矢口裕章; 布村菫; 石丸誠己; 水島慶一; 工藤彰彦; 佐藤翔紀; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 南尚哉; 中道一生; 松野吉宏; 田中伸哉; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 63rd, 2022年 - サーベイランス結果に基づく北海道におけるsporadic Creutzfeldt-Jakob diseaseの疫学
佐藤翔紀; 岩田育子; 濱田晋輔; 白井慎一; 松島理明; 矢口裕章; 佐藤克也; 北本哲之; 森若文雄; 水澤英洋; 山田正仁; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 63rd, 2022年 - 免疫介在性小脳失調症における新規自己抗体の検討
工藤彰彦; 矢口裕章; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 水戸泰紀; 田島康敬; 渡部昌; 畠山鎮次; 米田誠; 田中惠子; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 63rd, 2022年 - 中枢神経悪性リンパ腫の検討
水島慶一; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 清水亜衣; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 63rd, 2022年 - 非流暢/先文法型原発性進行性失語:脳血流・イオフルパンSPECTと症候・経過の関係
大槻美佳; 中川賀嗣; 輿水修一; 緒方昭彦; 新保和賢; 水戸泰紀; 田島康敬; 濱田晋輔; 浦茂久; 金藤公人; 保前英希; 岩田育子; 松島理明; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 63rd, 2022年 - 高度難聴、視力低下、著明な脳石灰化を主症状としたミトコンドリア病(m.12264C>T)の1例
大岩 慧; 瀬尾 祥; 足澤 萌奈美; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 長沼 亮滋; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 西山 一三; 後藤 雄一, 臨床神経学, 61, 7, 502, 502, 2021年07月
(一社)日本神経学会, 日本語 - B症状や末梢神経障害を契機に診断された、クリオグロブリン(CG)血管炎の1例
足澤 萌奈美; 大岩 慧; 瀬尾 祥; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 原田 晋平; 遠藤 知之; 矢部 一郎, 臨床神経学, 61, 7, 503, 503, 2021年07月
(一社)日本神経学会, 日本語 - 大脳皮質脳炎で再発した抗MOG抗体陽性脳炎の1例
田中 大貴; 大岩 慧; 瀬尾 祥; 足澤 萌奈美; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎, 臨床神経学, 61, 7, 503, 503, 2021年07月
(一社)日本神経学会, 日本語 - AIDS治療中に脳梗塞で発症し,原因検索に苦慮した中枢神経限局性血管炎の1例
足澤萌奈美; 江口克紀; 阿部恵; 岩田育子; 松島理明; 橋本大吾; 杉山拓; 矢部一郎, Neuroinfection (Web), 26, 2, 2021年 - B症状や末梢神経障害を契機に診断された,クリオグロブリン(CG)血管炎の1例
足澤萌奈美; 大岩慧; 瀬尾祥; 田中大貴; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 原田晋平; 遠藤知之; 矢部一郎, 臨床神経学(Web), 61, 7, 2021年 - 高度難聴,視力低下,著明な脳石灰化を主症状としたミトコンドリア病(m.12264C>T)の1例
大岩慧; 瀬尾祥; 足澤萌奈美; 田中大貴; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 長沼亮滋; 白井慎一; 岩田育子; 松島理明; 矢部一郎; 西山一三; 後藤雄一, 臨床神経学(Web), 61, 7, 2021年 - 大脳皮質脳炎で再発した抗MOG抗体陽性脳炎の1例
田中大貴; 大岩慧; 瀬尾祥; 足澤萌奈美; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢部一郎, 臨床神経学(Web), 61, 7, 2021年 - 感覚障害を合併し遠位優位の筋力低下を生じた重症筋無力症の1例
工藤彰彦; 大岩慧; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 矢部一郎, 神経治療学(Web), 38, 6, 2021年 - 姿勢推定機械学習モデルを利用した正常圧水頭症患者の歩行ケイデンス定量評価
江口克紀; 白井慎一; 岩田育子; 松島理明; 矢口裕章; 矢部一郎, 神経治療学(Web), 38, 6, 2021年 - 舞踏病を初発症状とした続発性抗リン脂質抗体症候群の1例
藤井信太朗; 大嶌祐貴; 堀内一宏; 岩見昴亮; 野村太一; 長井梓; 江口克紀; 脇田雅大; 佐藤智香; 長沼亮滋; 白井慎一; 岩田育子; 松島理明; 加藤将; 矢部一郎, 臨床神経学(Web), 61, 1, 2021年 - 北海道におけるプリオン病サーベイランス状況について
岩田育子; 濱田晋輔; 白井慎一; 松島理明; 森若文雄; 矢部一郎; 佐々木秀直, 臨床神経学(Web), 61, 1, 2021年 - 非定型Logopenic型原発性進行性失語様の言語症状を呈した若年性Alzheimer病の1例
足澤萌奈美; 大岩慧; 瀬尾祥; 田中大貴; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 大槻美佳; 矢部一郎, 臨床神経学(Web), 61, 1, 2021年 - 長大な脊髄病変を繰り返したBing-Neel症候群の1例
大岩慧; 瀬尾祥; 足澤萌奈美; 田中大貴; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢部一郎; 大東寛幸; 新野正明, 臨床神経学(Web), 61, 1, 2021年 - 非流暢/失文法型原発性進行性失語(naPPA)の発症・症候・検査所見・経過:55名の検討
大槻美佳; 中川賀嗣; 輿水修一; 新保和賢; 緒方昭彦; 水戸泰紀; 田島康敬; 濱田晋輔; 浦茂久; 岩田育子; 松島理明; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 62nd, 2021年 - 非集積地における遺伝性トランスサイレチン型アミロイドーシスの検討
市之川萌奈美; 大岩慧; 瀬尾祥; 田中大貴; 工藤彰彦; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 62nd, 2021年 - 肥厚性硬膜炎13例の後方視的検討
工藤彰彦; 大岩慧; 瀬尾祥; 足澤萌奈美; 田中大貴; 阿部恵; 江口克紀; 長井梓; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢部一郎, 日本神経学会学術大会プログラム・抄録集, 62nd, 2021年 - 剖検によりはじめて診断に至った孤発性Creutzfeldt-Jakob病(sCJD)MM2皮質型の80代男性例
豊島 貴信; 中村 洋祐; 中山 智央; 伊藤 規絵; 大久保 由希子; 小林 信義; 千葉 進; 岩田 育子; 矢部 一郎; 佐々木 秀直, 臨床神経学, 61, 1, 53, 53, 2021年01月
(一社)日本神経学会, 日本語 - 北海道におけるプリオン病サーベイランス状況について
岩田 育子; 濱田 晋輔; 白井 慎一; 松島 理明; 森若 文雄; 矢部 一郎; 佐々木 秀直, 臨床神経学, 61, 1, 53, 53, 2021年01月
(一社)日本神経学会, 日本語 - 舞踏病を初発症状とした続発性抗リン脂質抗体症候群の1例
藤井 信太朗; 大嶌 祐貴; 堀内 一宏; 岩見 昴亮; 野村 太一; 長井 梓; 江口 克紀; 脇田 雅大; 佐藤 智香; 長沼 亮滋; 白井 慎一; 岩田 育子; 松島 理明; 加藤 将; 矢部 一郎, 臨床神経学, 61, 1, 54, 54, 2021年01月
(一社)日本神経学会, 日本語 - 長大な脊髄病変を繰り返したBing-Neel症候群の1例
大岩 慧; 瀬尾 祥; 足澤 萌奈美; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 大東 寛幸; 新野 正明, 臨床神経学, 61, 1, 54, 54, 2021年01月
(一社)日本神経学会, 日本語 - 非定型Logopenic型原発性進行性失語様の言語症状を呈した若年性Alzheimer病の1例
足澤 萌奈美; 大岩 慧; 瀬尾 祥; 田中 大貴; 工藤 彰彦; 阿部 恵; 江口 克紀; 長井 梓; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 大槻 美佳; 矢部 一郎, 臨床神経学, 61, 1, 55, 55, 2021年01月
(一社)日本神経学会, 日本語 - 診断に苦慮した、高齢発症で家族歴の明らかではない遺伝性トランスサイレチン型アミロイドポリニューロパチーの2例
野村 太一; 松島 理明; 大嶌 祐貴; 芳野 正修; 水島 慶一; 江口 克紀; 脇田 雅大; 白井 慎一; 岩田 育子; 甲谷 太郎; 今本 鉄平; 岡田 宏美; 矢部 一郎; 佐々木 秀直, 末梢神経, 31, 2, 381, 381, 2020年12月
日本末梢神経学会, 日本語 - 複合免疫不全症の診断を契機に進行性多巣性白質脳症が判明した若年女性の1例
岩見 昂亮; 松島 理明; 長井 梓; 白井 慎一; 中久保 祥; 岩田 育子; 山田 雅文; 矢部 一郎, 神経治療学, 37, 6, S245, S245, 2020年10月
(一社)日本神経治療学会, 日本語 - 神経内ガングリオンと考えられた神経内多発嚢胞性病変による脛骨神経麻痺
江口 克紀; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎, 臨床神経学, 60, 8, 549, 553, 2020年08月
(一社)日本神経学会, 日本語 - Emery-Dreifuss型筋ジストロフィー(EDMD)の1例
藤井信太朗; 岩見昴亮; 野村太一; 高橋俊樹; 長井梓; 江口克紀; 脇田雅大; 佐藤智香; 長沼亮滋; 白井慎一; 岩田育子; 松島理明; 矢部一郎; 藤田篤史; 西野一三, 臨床神経学(Web), 60, 1, 2020年 - 高齢発症で家族歴がなく,診断に時間を要した家族性アミロイドポリニューロパチーの2例
野村太一; 大嶌祐貴; 芳野正修; 水島慶一; 江口克紀; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢部一郎; 佐々木秀直, 臨床神経学(Web), 60, 1, 2020年 - 脊髄性筋萎縮症3型成人例へのヌシネルセン投与経験
岩見昂亮; 芳野正修; 水島慶一; 大嶌祐貴; 江口克紀; 脇田雅大; 佐藤智香; 長沼亮滋; 白井慎一; 岩田育子; 松島理明; 相馬広幸; 矢部一郎; 佐々木秀直, 臨床神経学(Web), 60, 1, 2020年 - 複合免疫不全症の診断を契機に進行性多巣性白質脳症が判明した若年女性の1例
岩見昂亮; 松島理明; 長井梓; 白井慎一; 中久保祥; 岩田育子; 山田雅文; 矢部一郎, 神経治療学(Web), 37, 6, 2020年 - 高齢発症で家族歴がなく、診断に時間を要した家族性アミロイドポリニューロパチーの2例
野村 太一; 大嶌 祐貴; 芳野 正修; 水島 慶一; 江口 克紀; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 佐々木 秀直, 臨床神経学, 60, 1, 93, 93, 2020年01月
(一社)日本神経学会, 日本語 - 脊髄性筋萎縮症3型成人例へのヌシネルセン投与経験
岩見 昂亮; 芳野 正修; 水島 慶一; 大嶌 祐貴; 江口 克紀; 脇田 雅大; 佐藤 智香; 長沼 亮滋; 白井 慎一; 岩田 育子; 松島 理明; 相馬 広幸; 矢部 一郎; 佐々木 秀直, 臨床神経学, 60, 1, 95, 95, 2020年01月
(一社)日本神経学会, 日本語 - ステロイド、免疫グロブリン静注療法が著効したシェーグレン症候群に伴う自己免疫性自律神経節障害の1例
江口 克紀; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 佐々木 秀直, 神経治療学, 36, 6, S275, S275, 2019年10月
(一社)日本神経治療学会, 日本語 - タンデムマス検査が有用であった極長鎖アシルCoA脱水素酵素(VLCAD)欠損症の1例
水島 慶一; 白井 慎一; 江口 克紀; 脇田 雅大; 佐藤 智香; 岩田 育子; 松島 理明; 佐藤 和則; 相崎 潤子; 但馬 剛; 矢部 一郎; 佐々木 秀直, 臨床神経学, 59, 6, 393, 393, 2019年06月
(一社)日本神経学会, 日本語 - 失調症状を主としたX連鎖性Charcot-Marie-Tooth病1型(CMTX1)の1例
大嶌 祐貴; 水島 慶一; 芳野 正修; 江口 克紀; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 高嶋 博; 佐々木 秀直, 臨床神経学, 59, 6, 395, 395, 2019年06月
(一社)日本神経学会, 日本語 - 刺激装置の変更により脳深部刺療法による開眼失行が改善したパーキンソン病の1例
江口 克紀; 白井 慎一; 大嶌 祐貴; 水島 慶一; 芳野 正修; 脇田 雅大; 岩田 育子; 松島 理明; 山崎 和義; 濱内 祝嗣; 笹森 徹; 関 俊隆; 矢部 一郎; 寳金 清博; 佐々木 秀直, 臨床神経学, 59, 6, 395, 395, 2019年06月
(一社)日本神経学会, 日本語 - LCIGの導入後にPEG/Jチューブにより十二指腸潰瘍を発症した1例
芳野 正修; 白井 慎一; 大嶌 祐貴; 水島 慶一; 江口 克紀; 脇田 雅大; 佐藤 智香; 長沼 亮滋; 上床 尚; 岩田 育子; 松島 理明; 矢部 一郎; 小野 尚子; 浦 茂久; 太田 勝久; 佐々木 秀直, 臨床神経学, 59, 6, 396, 396, 2019年06月
(一社)日本神経学会, 日本語 - タンデムマス検査が有用であった極長鎖アシルCoA脱水素酵素(VLCAD)欠損症の1例
水島 慶一; 白井 慎一; 江口 克紀; 脇田 雅大; 佐藤 智香; 岩田 育子; 松島 理明; 佐藤 和則; 相崎 潤子; 但馬 剛; 矢部 一郎; 佐々木 秀直, 臨床神経学, 59, 6, 393, 393, 2019年06月
(一社)日本神経学会, 日本語 - 失調症状を主としたX連鎖性Charcot-Marie-Tooth病1型(CMTX1)の1例
大嶌 祐貴; 水島 慶一; 芳野 正修; 江口 克紀; 脇田 雅大; 白井 慎一; 岩田 育子; 松島 理明; 矢部 一郎; 高嶋 博; 佐々木 秀直, 臨床神経学, 59, 6, 395, 395, 2019年06月
(一社)日本神経学会, 日本語 - LCIGの導入後にPEG/Jチューブにより十二指腸潰瘍を発症した1例
芳野 正修; 白井 慎一; 大嶌 祐貴; 水島 慶一; 江口 克紀; 脇田 雅大; 佐藤 智香; 長沼 亮滋; 上床 尚; 岩田 育子; 松島 理明; 矢部 一郎; 小野 尚子; 浦 茂久; 太田 勝久; 佐々木 秀直, 臨床神経学, 59, 6, 396, 396, 2019年06月
(一社)日本神経学会, 日本語 - 刺激装置の変更により脳深部刺療法による開眼失行が改善したパーキンソン病の1例
江口 克紀; 白井 慎一; 大嶌 祐貴; 水島 慶一; 芳野 正修; 脇田 雅大; 岩田 育子; 松島 理明; 山崎 和義; 濱内 祝嗣; 笹森 徹; 関 俊隆; 矢部 一郎; 寳金 清博; 佐々木 秀直, 臨床神経学, 59, 6, 395, 395, 2019年06月
(一社)日本神経学会, 日本語 - Expression change of plasma microRNAs in mutiple system atrophy and Parkinson's disease
Hisashi Uwatoko; Yuka Hama; Shinichi Shirai; Ikuko Takahashi; Masaaki Matsushima; Hideki Houzen; Kazufumi Tsuzaka; Ichiro Yabe; Hidenao Sasaki, NEUROLOGY, 92, 15, 2019年04月
英語, 研究発表ペーパー・要旨(国際会議) - 刺激装置の変更により脳深部刺激法による開眼失行が改善したパーキンソン病の1例
江口克紀; 白井慎一; 大嶌祐貴; 水島慶一; 芳野正修; 脇田雅大; 岩田育子; 松島理明; 山崎和義; 濱内祝嗣; 笹森徹; 関俊隆; 矢部一郎; 寶金清博; 佐々木秀直, 臨床神経学(Web), 59, 6, 2019年 - タンデムマス検査が有用であった極長鎖アシルCoA脱水素酵素(VLCAD)欠損症の1例
水島慶一; 白井慎一; 江口克紀; 脇田雅大; 佐藤智香; 岩田育子; 松島理明; 佐藤和則; 相崎潤子; 但馬剛; 矢部一郎; 佐々木秀直, 臨床神経学(Web), 59, 6, 2019年 - LCIGの導入後にPEG/Jチューブにより十二指腸潰瘍を発症した1例
芳野正修; 白井慎一; 大嶌祐貴; 水島慶一; 江口克紀; 脇田雅大; 佐藤智香; 長沼亮滋; 上床尚; 岩田育子; 松島理明; 矢部一郎; 小野尚子; 浦茂久; 太田勝久; 佐々木秀直, 臨床神経学(Web), 59, 6, 2019年 - 失調症状を主としたX連鎖性Charcot-Marie-Tooth病1型(CMTX1)の1例
大嶌祐貴; 水島慶一; 芳野正修; 江口克紀; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢部一郎; 高嶋博; 佐々木秀直, 臨床神経学(Web), 59, 6, 2019年 - ステロイド,免疫グロブリン静注療法が著効したシェーグレン症候群に伴う自己免疫性自律神経節障害の1例
江口克紀; 脇田雅大; 白井慎一; 岩田育子; 松島理明; 矢部一郎; 佐々木秀直, 神経治療学(Web), 36, 6, 2019年 - ADENOSINE A2A RECEPTOR ANTAGONIST ISTRADEFYLLINE IMPROVES LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE IN A LONG-TERM PERIOD
T. Kitta; Yabe, I; Y. Kanno; M. Ouchi; M. Higuchi; M. Togo; K. Moriya; Takahashi, I; M. Matsushima; H. Sasaki; N. Shinohara, NEUROUROLOGY AND URODYNAMICS, 36, S535, S536, 2017年07月
英語, 研究発表ペーパー・要旨(国際会議) - LONG-TERM OUTCOME OF ADENOSINE A2A RECEPTOR ANTAGONIST ON LOWER URINARY TRACT SYMPTOMS IN MALE PARKINSON'S DISEASE PATIENTS
Takeya Kitta; Ichiro Yabe; Yukiko Kanno; Ouchi Mifuka; Kimihiko Moriya; Ikuko Takahashi; Masaaki Matsushima; Hidenao Sasaki; Nobuo Shinohara, JOURNAL OF UROLOGY, 197, 4, E1263, E1264, 2017年04月
英語, 研究発表ペーパー・要旨(国際会議) - Spinocerebellar ataxia type 14 family with a novel PRKCG mutation
Ichiro Yabe; Mari Kimura; Shinichi Shirai; Ikuko Takahashi; Masaaki Matsushima; Hidenao Sasaki, NEUROLOGY AND CLINICAL NEUROSCIENCE, 4, 5, 199, +, 2016年09月
英語, その他 - CLINICAL EFFICACY OF ADENOSINE A2A RECEPTOR ANTAGONIST ON LOWER URINARY TRACT SYMPTOMS IN PARKINSON'S DISEASE: A PROSPECTIVE STUDY
Takeya Kitta; Ichiro Yabe; Yukiko Kanno; Kimihiko Moriya; Ikuko Takahashi; Masaaki Matsushima; Hidenao Sasaki; Nobuo Shinohara, JOURNAL OF UROLOGY, 195, 4, E186, E187, 2016年04月
英語, 研究発表ペーパー・要旨(国際会議) - FTD and PSP-like syndrome with a novel TARDBP mutation.
Yabe, I; Nakano, F; Shirai, S; Matsushima, M; Takahashi, I; Sasaki, H, Neurology Clin Neurosci, 4, 76, 77, 2016年, [査読有り]
英語
- 全科臨床実習, 2024年, 学士課程, 医学部
- 基本医学研究, 2024年, 修士課程, 医学院
- 診療参加型選択科臨床実習, 2024年, 学士課程, 医学部
- 基本医学総論, 2024年, 修士課程, 医学院
- 医学総論, 2024年, 博士後期課程, 医学研究科
- 医学総論, 2024年, 博士後期課程, 医学院
- 基盤医学研究, 2024年, 博士後期課程, 医学院
- 臨床医学研究, 2024年, 博士後期課程, 医学院
- 神経障害学Ⅲ, 2024年, 学士課程, 医学部
- 神経障害学Ⅰ, 2024年, 学士課程, 医学部
